Document:

Exhibit
10.2

 

Execution
Version

 

REGISTRATION
RIGHTS AGREEMENT

 

This
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 12, 2021, is by and between B.
Riley Principal Capital, LLC, a Delaware limited liability company (the “Investor”), and Cinedigm Corp., a
Delaware corporation (the “Company”).

 

RECITALS

 

A.
The Company and the Investor have entered into that certain Common Stock Purchase Agreement, dated as of the date hereof (the “Purchase
Agreement”), pursuant to which the Company may issue, from time to time, to the Investor up to the lesser of (i) $50,000,000
in aggregate gross purchase price of newly issued shares of the Company’s Class A common stock, par value $0.001 per share (“Common
Stock”), and (ii) the Exchange Cap (to the extent applicable under Section 3.3 of the Purchase Agreement), as provided
for therein.

 

B.
Pursuant to the terms of, and in consideration for the Investor entering into, the Purchase Agreement, the Company shall cause to be
issued to the Investor the Commitment Shares in accordance with the terms of the Purchase Agreement.

 

C.
Pursuant to the terms of, and in consideration for the Investor entering into, the Purchase Agreement, and to induce the Investor to
execute and deliver the Purchase Agreement, the Company has agreed to provide the Investor with certain registration rights with respect
to the Registrable Securities (as defined herein) as set forth herein.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the representations, warranties, covenants and agreements contained herein and in the Purchase Agreement,
and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, intending to be legally bound
hereby, the Company and the Investor hereby agree as follows:

 

		1.	Definitions.

 

Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement. As used in
this Agreement, the following terms shall have the following meanings:

 

(a)
“Agreement” shall have the meaning assigned to such term in the preamble of this Agreement

 

(b)
“Allowable Grace Period” shall have the meaning assigned to such term in Section 3(p).

 

(c)
“Blue Sky Filing” shall have the meaning assigned to such term in Section 6(a).

 

(d)
“Business Day” means any day other than Saturday, Sunday or any other day on which commercial banks in New
York, New York are authorized or required by law to remain closed.

 

    

     

    

 

(e)
“Claims” shall have the meaning assigned to such term in Section 6(a).

 

(f)
“Closing Date” shall mean the date of this Agreement.

 

(g)
“Commission” means the U.S. Securities and Exchange Commission or any successor entity.

 

(h)
“Common Stock” shall have the meaning assigned to such term in the recitals to this Agreement.

 

(i)
“Company” shall have the meaning assigned to such term in the preamble of this Agreement.

 

(j)
“Effective Date” means the date that the applicable Registration Statement has been declared effective by the
Commission.

 

(k)
“Effectiveness Deadline” means (i) with respect to the Initial Registration Statement required to be filed
to pursuant to Section 2(a), the earlier of (A) the 90th calendar day after the date of this Agreement, if such Registration
Statement is subject to review by the Commission, and (B) the 60th calendar day after the date of this Agreement, if the Company
is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be reviewed and
(ii) with respect to any New Registration Statements that may be required to be filed by the Company pursuant to this Agreement, the
earlier of (A) the 90th calendar day following the date on which the Company was required to file such additional Registration
Statement, if such Registration Statement is subject to review by the Commission, and (B) the 45th calendar day following
the date on which the Company was required to file such New Registration Statement, if the Company is notified (orally or in writing,
whichever is earlier) by the Commission that such Registration Statement will not be reviewed.

 

(l)
“Filing Deadline” means (i) with respect to the Initial Registration Statement required to be filed to pursuant
to Section 2(a), the 10th Business Day after the date of this Agreement and (ii) with respect to any New Registration Statements
that may be required to be filed by the Company pursuant to this Agreement, the 10th Business Day following the sale of substantially
all of the Registrable Securities included in the Initial Registration Statement or the most recent prior New Registration Statement,
as applicable, or such other date as permitted by the Commission.

 

(m)
“Indemnified Damages” shall have the meaning assigned to such term in Section 6(a).

 

(n)
“Initial Registration Statement” shall have the meaning assigned to such term in Section 2(a).

 

(o)
“Investor” shall have the meaning assigned to such term in the preamble of this Agreement.

 

(p)
“Investor Party” and “Investor Parties” shall have the meaning assigned to such terms in Section
6(a).

 

    2

     

    

 

(q)
“Legal Counsel” shall have the meaning assigned to such term in Section 2(b).

 

(r)
“New Registration Statement” shall have the meaning assigned to such term in Section 2(c).

 

(s)
“Person” means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership,
limited liability company, trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.

 

(t)
“Prospectus” means the prospectus in the form included in the Registration Statement, as supplemented from
time to time by any Prospectus Supplement, including the documents incorporated by reference therein.

 

(u)
“Prospectus Supplement” means any prospectus supplement to the Prospectus filed with the Commission from time
to time pursuant to Rule 424(b) under the Securities Act, including the documents incorporated by reference therein.

 

(v)
“Purchase Agreement” shall have the meaning assigned to such term in the recitals to this Agreement.

 

(w)
“register,” “registered,” and “registration” refer to a
registration effected by preparing and filing one or more Registration Statements in compliance with the Securities Act and pursuant
to Rule 415 and the declaration of effectiveness of such Registration Statement(s) by the Commission.

 

(x)
“Registrable Securities” means all of (i) the Shares, (ii) the Commitment Shares, and (iii) any capital stock
of the Company issued or issuable with respect to such Shares or Commitment Shares, including, without limitation, (1) as a result of
any stock split, stock dividend, recapitalization, exchange or similar event or otherwise and (2) shares of capital stock of the Company
into which the shares of Common Stock are converted or exchanged and shares of capital stock of a successor entity into which the shares
of Common Stock are converted or exchanged, in each case until such time as such securities cease to be Registrable Securities pursuant
to Section 2(f).

 

(y)
“Registration Statement” means a registration statement or registration statements of the Company filed under
the Securities Act covering the resale by the Investor of Registrable Securities, as such registration statement or registration statements
may be amended and supplemented from time to time, including all documents filed as part thereof or incorporated by reference therein.

 

(z)
“Registration Period” shall have the meaning assigned to such term in Section 3(a).

 

(aa)
“Rule 144” means Rule 144 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission that may at any time permit the Investor to
sell securities of the Company to the public without registration.

 

    3

     

    

 

(bb)
“Rule 415” means Rule 415 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission providing for offering securities on a delayed
or continuous basis.

 

(cc)
“Staff” shall have the meaning assigned to such term in Section 2(e).

 

(dd)
“Violations” shall have the meaning assigned to such term in Section 6(a).

 

		2.	Registration.

 

(a)
Mandatory Registration. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline,
file with the Commission the Initial Registration Statement on Form S-1 (or any successor form) covering the resale by the Investor of
(i) all of the Commitment Shares and (ii) the maximum number of additional Registrable Securities as shall be permitted to be included
thereon in accordance with applicable Commission rules, regulations and interpretations so as to permit the resale of such Registrable
Securities by the Investor under Rule 415 under the Securities Act at then prevailing market prices (and not fixed prices) (the “Initial
Registration Statement”). The Initial Registration Statement shall contain the “Selling Stockholder” and “Plan
of Distribution” sections in substantially the form attached hereto as Exhibit B. The Company shall use its commercially
reasonable efforts to have the Initial Registration Statement declared effective by the Commission as soon as reasonably practicable,
but in no event later than the applicable Effectiveness Deadline.

 

(b)
Legal Counsel. Subject to Section 5 hereof, the Investor shall have the right to select one legal counsel to review and oversee,
solely on its behalf, any registration pursuant to this Section 2 (“Legal Counsel”), which shall be Dorsey
& Whitney LLP, or such other counsel as thereafter designated by the Investor. Except as provided under Section 10.1(i) of the Purchase
Agreement, the Company shall have no obligation to reimburse the Investor for any and all legal fees and expenses of the Legal Counsel
incurred in connection with the transactions contemplated hereby.

 

(c)
Sufficient Number of Shares Registered. If at any time all Registrable Securities are not covered by the Initial Registration
Statement filed pursuant to Section 2(a) as a result of Section 2(e) or otherwise, the Company shall use its commercially reasonable
efforts to file with the Commission one or more additional Registration Statements so as to cover all of the Registrable Securities not
covered by the Initial Registration Statement, in each case, as soon as practicable (taking into account any position of the staff of
the Commission (“Staff”) with respect to the date on which the Staff will permit such additional Registration
Statement(s) to be filed with the Commission and the rules and regulations of the Commission) (each such additional Registration Statement,
a “New Registration Statement”), but in no event later than the applicable Filing Deadline for such New Registration
Statement(s). The Company shall use its commercially reasonable efforts to cause each such New Registration Statement to become effective
as soon as practicable following the filing thereof with the Commission, but in no event later than the applicable Effectiveness Deadline
for such New Registration Statement.

 

(d)
No Inclusion of Other Securities. In no event shall the Company include any securities other than Registrable Securities on any
Registration Statement pursuant to Section 2(a) or Section 2(c) without consulting the Investor and Legal Counsel prior to filing such
Registration Statement with the Commission.

 

    4

     

    

 

(e)
Offering. If the Staff or the Commission seeks to characterize any offering pursuant to a Registration Statement filed pursuant
to this Agreement as constituting an offering of securities that does not permit such Registration Statement to become effective and
be used for resales by the Investor on a delayed or continuous basis under Rule 415 at then-prevailing market prices (and not fixed prices),
or if after the filing of any Registration Statement pursuant to Section 2(a) or Section 2(c), the Company is otherwise required by the
Staff or the Commission to reduce the number of Registrable Securities included in such Registration Statement, then the Company shall
reduce the number of Registrable Securities to be included in such Registration Statement (after consultation with the Investor and Legal
Counsel as to the specific Registrable Securities to be removed therefrom) until such time as the Staff and the Commission shall so permit
such Registration Statement to become effective and be used as aforesaid. Notwithstanding anything in this Agreement to the contrary,
if after giving effect to the actions referred to in the immediately preceding sentence, the Staff or the Commission does not permit
such Registration Statement to become effective and be used for resales by the Investor on a delayed or continuous basis under Rule 415
at then-prevailing market prices (and not fixed prices), the Company shall not request acceleration of the Effective Date of such Registration
Statement, the Company shall promptly (but in no event later than 48 hours) request the withdrawal of such Registration Statement pursuant
to Rule 477 under the Securities Act, and the Effectiveness Deadline shall automatically be deemed to have elapsed with respect to such
Registration Statement at such time as the Staff or the Commission has made a final and non-appealable determination that the Commission
will not permit such Registration Statement to be so utilized (unless prior to such time the Company has received assurances from the
Staff or the Commission that a New Registration Statement filed by the Company with the Commission promptly thereafter may be so utilized).
In the event of any reduction in Registrable Securities pursuant to this paragraph, the Company shall use its commercially reasonable
efforts to file one or more New Registration Statements with the Commission in accordance with Section 2(c) until such time as all Registrable
Securities have been included in Registration Statements that have been declared effective and the Prospectuses contained therein are
available for use by the Investor.

 

(f)
Any Registrable Security shall cease to be a “Registrable Security” at the earliest of the following: (i) when a Registration
Statement covering such Registrable Security becomes or has been declared effective by the Commission and such Registrable Security has
been sold or disposed of pursuant to such effective Registration Statement; (ii) when such Registrable Security is held by the Company
or one of its Subsidiaries; and (iii) the date that is the later of (A) the first (1st) anniversary of the date of termination
of the Purchase Agreement in accordance with Article VIII of the Purchase Agreement and (B) the first (1st) anniversary of
the date of the last sale of any Registrable Securities to the Investor pursuant to the Purchase Agreement.

 

    5

     

    

 

		3.	Related
                                            Obligations.

 

The
Company shall use its commercially reasonable efforts to effect the registration of the Registrable Securities in accordance with the
intended method of disposition thereof, and, pursuant thereto, during the term of this Agreement, the Company shall have the following
obligations:
 

(a)
The Company shall promptly prepare and file with the Commission the Initial Registration Statement pursuant to Section 2(a) hereof and
one or more New Registration Statements pursuant to Section 2(c) hereof with respect to the Registrable Securities, but in no event later
than the applicable Filing Deadline therefor, and the Company shall use its commercially reasonable efforts to cause each such Registration
Statement to become effective as soon as practicable after such filing, but in no event later than the applicable Effectiveness Deadline
therefor. Subject to Allowable Grace Periods, the Company shall keep each Registration Statement effective (and the Prospectus contained
therein available for use) pursuant to Rule 415 for resales by the Investor on a continuous basis at then-prevailing market prices (and
not fixed prices) at all times until the earlier of (i) the date on which the Investor shall have sold all of the Registrable Securities
covered by such Registration Statement and (ii) the date of termination of the Purchase Agreement if as of such termination date the
Investor holds no Registrable Securities (or, if applicable, the date on which such securities cease to be Registrable Securities after
the date of termination of the Purchase Agreement) (the “Registration Period”). Notwithstanding anything to
the contrary contained in this Agreement (but subject to the provisions of Section 3(q) hereof), the Company shall ensure that, when
filed and at all times while effective, each Registration Statement (including, without limitation, all amendments and supplements thereto)
and the Prospectus (including, without limitation, all amendments and supplements thereto) used in connection with such Registration
Statement shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or
necessary to make the statements therein (in the case of Prospectuses, in the light of the circumstances in which they were made) not
misleading. The Company shall submit to the Commission, as soon as reasonably practicable after the date that the Company learns that
no review of a particular Registration Statement will be made by the Staff or that the Staff has no further comments on a particular
Registration Statement (as the case may be), a request for acceleration of effectiveness of such Registration Statement to a time and
date as soon as reasonably practicable in accordance with Rule 461 under the Securities Act.

 

(b)
Subject to Section 3(q) of this Agreement, the Company shall use its commercially reasonable efforts to prepare and file with the Commission
such amendments (including, without limitation, post-effective amendments) and supplements to each Registration Statement and the Prospectus
used in connection with each such Registration Statement, which Prospectus is to be filed pursuant to Rule 424 promulgated under the
Securities Act, as may be necessary to keep each such Registration Statement effective (and the Prospectus contained therein current
and available for use) at all times during the Registration Period for such Registration Statement, and, during such period, comply with
the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company required to be covered
by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the
intended methods of disposition by the Investor. Without limiting the generality of the foregoing, the Company covenants and agrees that
(i) at or before 8:30 a.m. (New York City time) on the Trading Day immediately following the Effective Date of the Initial Registration
Statement and any New Registration Statement (or any post-effective amendment thereto), the Company shall file with the Commission in
accordance with Rule 424(b) under the Securities Act the final Prospectus to be used in connection with sales pursuant to such Registration
Statement (or post-effective amendment thereto), and (ii) if the transactions contemplated by any VWAP Purchase are material to the Company
(individually or collectively with all other prior VWAP Purchases, the consummation of which have not previously been reported in any
Prospectus Supplement filed with the Commission under Rule 424(b) under the Securities Act or in any report, statement or other document
filed by the Company with the Commission under the Exchange Act), or if otherwise required under the Securities Act (or the interpretations
of the Commission thereof), in each case as reasonably determined by the Company and the Investor, then, at or before 8:30 a.m., New
York City time, on the first (1st) Trading Day immediately following the VWAP Purchase Date, if a VWAP Purchase Notice was
properly delivered to the Investor hereunder in connection with such VWAP Purchase, the Company shall file with the Commission a Prospectus
Supplement pursuant to Rule 424(b) under the Securities Act with respect to the VWAP Purchase(s), the total VWAP Purchase Price for the
Shares subject to such VWAP Purchase(s) (as applicable), the applicable VWAP Purchase Price(s) for such Shares and the net proceeds that
are to be (and, if applicable, have been) received by the Company from the sale of such Shares. To the extent not previously disclosed
in the Prospectus or a Prospectus Supplement, the Company shall disclose in its Quarterly Reports on Form 10-Q and in its Annual Reports
on Form 10-K the information described in the immediately preceding sentence relating to all VWAP Purchase(s) consummated during the
relevant fiscal quarter and shall file such Quarterly Reports and Annual Reports with the Commission within the applicable time period
prescribed for such report under the Exchange Act. In the case of amendments and supplements to any Registration Statement on Form S-1
or Prospectus related thereto which are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this
Section 3(b)) by reason of the Company filing a report on Form 8-K, Form 10-Q or Form 10-K or any analogous report under the Exchange
Act, the Company shall have incorporated such report by reference into such Registration Statement and Prospectus, if applicable, or
shall file such amendments or supplements to the Registration Statement or Prospectus with the Commission on the same day on which the
Exchange Act report is filed which created the requirement for the Company to amend or supplement such Registration Statement or Prospectus,
for the purpose of including or incorporating such report into such Registration Statement and Prospectus. The Company consents to the
use of the Prospectus (including, without limitation, any supplement thereto) included in each Registration Statement in accordance with
the provisions of the Securities Act and with the securities or “Blue Sky” laws of the jurisdictions in which the Registrable
Securities may be sold by the Investor, in connection with the resale of the Registrable Securities and for such period of time thereafter
as such Prospectus (including, without limitation, any supplement thereto) (or in lieu thereof, the notice referred to in Rule 173(a)
under the Securities Act) is required by the Securities Act to be delivered in connection with resales of Registrable Securities.

 

    6

     

    

 

(c)
The Company shall (A) permit Legal Counsel an opportunity to review and comment upon (i) each Registration Statement at least two (2)
Business Days prior to its filing with the Commission and (ii) all amendments and supplements to each Registration Statement (including,
without limitation, the Prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, and any similar or successor reports or Prospectus Supplements the contents of which is limited to that set forth
in such reports) within a reasonable number of days prior to their filing with the Commission, and (B) shall reasonably consider any
comments of the Investor and Legal Counsel on any such Registration Statement or amendment or supplement thereto or to any Prospectus
contained therein. The Company shall promptly furnish to Legal Counsel, without charge, (i) electronic copies of any correspondence from
the Commission or the Staff to the Company or its representatives relating to each Registration Statement (which correspondence shall
be redacted to exclude any material, non-public information regarding the Company or any of its Subsidiaries), (ii) after the same
is prepared and filed with the Commission, one (1) electronic copy of each Registration Statement and any amendment(s) and supplement(s)
thereto, including, without limitation, financial statements and schedules, all documents incorporated therein by reference, if requested
by the Investor, and all exhibits and (iii) upon the effectiveness of each Registration Statement, one (1) electronic copy of the
Prospectus included in such Registration Statement and all amendments and supplements thereto; provided, however, the Company shall not
be required to furnish any document (other than the Prospectus, which may be provided in .PDF format) to Legal Counsel to the extent
such document is available on EDGAR).

 

(d)
Without limiting any obligation of the Company under the Purchase Agreement, the Company shall promptly furnish to the Investor, without
charge, (i) after the same is prepared and filed with the Commission, at least one (1) electronic copy of each Registration Statement
and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents incorporated
therein by reference, if requested by the Investor, all exhibits thereto, (ii) upon the effectiveness of each Registration Statement,
one (1) electronic copy of the Prospectus included in such Registration Statement and all amendments and supplements thereto (or such
other number of copies as the Investor may reasonably request from time to time) and (iii) such other documents, including, without limitation,
copies of any final Prospectus and any Prospectus Supplement thereto, as the Investor may reasonably request from time to time in order
to facilitate the disposition of the Registrable Securities owned by the Investor; provided, however, the Company shall not be required
to furnish any document (other than the Prospectus, which may be provided in .PDF format) to the Investor to the extent such document
is available on EDGAR).

 

(e)
The Company shall take such action as is reasonably necessary to (i) register and qualify, unless an exemption from registration and
qualification applies, the resale by the Investor of the Registrable Securities covered by a Registration Statement under such other
securities or “Blue Sky” laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions,
such amendments (including, without limitation, post-effective amendments) and supplements to such registrations and qualifications as
may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be reasonably
necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv) take all
other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in
any jurisdiction where it would not otherwise be required to qualify but for this Section 3(e), (y) subject itself to general taxation
in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify
Legal Counsel and the Investor of the receipt by the Company of any notification with respect to the suspension of the registration or
qualification of any of the Registrable Securities for sale under the securities or “Blue Sky” laws of any jurisdiction in
the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.

 

    7

     

    

 

(f)
The Company shall notify Legal Counsel and the Investor in writing of the happening of any event, as promptly as reasonably practicable
after becoming aware of such event, as a result of which the Prospectus included in a Registration Statement, as then in effect, includes
an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain
any material, non-public information regarding the Company or any of its Subsidiaries), and, subject to Section 3(q), promptly prepare
a supplement or amendment to such Registration Statement and such Prospectus contained therein to correct such untrue statement or omission
and deliver one (1) electronic copy of such supplement or amendment to Legal Counsel and the Investor (or such other number of copies
as Legal Counsel or the Investor may reasonably request). The Company shall also promptly notify Legal Counsel and the Investor in writing
(i) when a Prospectus or any Prospectus Supplement or post-effective amendment has been filed, when a Registration Statement or any post-effective
amendment has become effective (notification of such effectiveness shall be delivered to Legal Counsel and the Investor by facsimile
or e-mail on the same day of such effectiveness), and when the Company receives written notice from the Commission that a Registration
Statement or any post-effective amendment will be reviewed by the Commission, (ii) of any request by the Commission for amendments or
supplements to a Registration Statement or related Prospectus or related information, (iii) of the Company’s reasonable determination
that a post-effective amendment to a Registration Statement would be appropriate and (iv) of the receipt of any request by the Commission
or any other federal or state governmental authority for any additional information relating to the Registration Statement or any amendment
or supplement thereto or any related Prospectus. The Company shall respond as promptly as reasonably practicable to any comments received
from the Commission with respect to a Registration Statement or any amendment thereto. Nothing in this Section 3(f) shall limit any obligation
of the Company under the Purchase Agreement.

 

(g)
The Company shall (i) use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness
of a Registration Statement or the use of any Prospectus contained therein, or the suspension of the qualification, or the loss of an
exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is
issued, to obtain the withdrawal of such order or suspension at the earliest possible time and (ii) notify Legal Counsel and the Investor
of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding.

 

(h)
The Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless
(i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in
such Registration Statement pursuant to the Securities Act, (iii) the release of such information is ordered pursuant to a subpoena or
other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made
generally available to the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company
agrees that it shall, upon learning that disclosure of such information concerning the Investor is sought in or by a court or governmental
body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor, at the Investor’s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.

 

    8

     

    

 

(i)
Without limiting any obligation of the Company under the Purchase Agreement, the Company shall use its commercially reasonable efforts
either to (i) cause all of the Registrable Securities covered by each Registration Statement to be listed on the Trading Market, or (ii)
secure designation and quotation of all of the Registrable Securities covered by each Registration Statement on another Eligible Market.
The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(i).

 

(j)
The Company shall cooperate with the Investor and, to the extent applicable, facilitate the timely preparation and delivery of Registrable
Securities, as DWAC Shares, to be offered pursuant to a Registration Statement and enable such DWAC Shares to be in such denominations
or amounts (as the case may be) as the Investor may reasonably request from time to time and registered in such names as the Investor
may request. Investor hereby agrees that it shall cooperate with the Company, its counsel and its transfer agent in connection with any
issuances of DWAC Shares, and hereby represents, warrants and covenants to the Company that that it will resell such DWAC Shares only
pursuant to the Registration Statement in which such DWAC Shares are included, in a manner described under the caption “Plan of
Distribution” in such Registration Statement, and in a manner in compliance with all applicable U.S. federal and state securities
laws, rules and regulations, including, without limitation, any applicable prospectus delivery requirements of the Securities Act. DWAC
Shares shall be free from all restrictive legends may be transmitted by the Company’s transfer agent to the Investor by crediting
an account at DTC as directed in writing by the Investor.

 

(k)
Upon the written request of the Investor, the Company shall as soon as reasonably practicable after receipt of notice from the Investor
and subject to Section 3(p) hereof, (i) incorporate in a Prospectus Supplement or post-effective amendment such information as the Investor
reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation,
information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any
other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such Prospectus
Supplement or post-effective amendment after being notified of the matters to be incorporated in such Prospectus Supplement or post-effective
amendment; and (iii) supplement or make amendments to any Registration Statement or Prospectus contained therein if reasonably requested
by the Investor.

 

(l)
The Company shall use its commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to
be registered with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of
such Registrable Securities.

 

(m)
The Company shall make generally available to its security holders (which may be satisfied by making such information available on EDGAR)
as soon as practical, but not later than ninety (90) days after the close of the period covered thereby, an earnings statement (in form
complying with, and in the manner provided by, the provisions of Rule 158 under the Securities Act) covering a twelve-month period beginning
not later than the first day of the Company’s fiscal quarter next following the applicable Effective Date of each Registration
Statement.

 

    9

     

    

 

(n)
The Company shall otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the Commission
in connection with any registration hereunder.

 

(o)
Within one (1) Business Day after each Registration Statement which covers Registrable Securities is declared effective by the Commission,
the Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investor) confirmation that such Registration Statement has been declared effective by the Commission in the form
attached hereto as Exhibit A.

 

(p)
Notwithstanding anything to the contrary contained herein (but subject to the last sentence of this Section 3(p)), at any time after
the Effective Date of a particular Registration Statement, the Company may, upon written notice to Investor, suspend Investor’s
use of any prospectus that is a part of any Registration Statement (in which event the Investor shall discontinue sales of the Registrable
Securities pursuant to such Registration Statement contemplated by this Agreement, but shall settle any previously made sales of Registrable
Securities) if the Company (x) is pursuing an acquisition, merger, tender offer, reorganization, disposition or other similar transaction
and the Company determines in good faith that (A) the Company’s ability to pursue or consummate such a transaction would be materially
adversely affected by any required disclosure of such transaction in such Registration Statement or other registration statement or (B)
such transaction renders the Company unable to comply with Commission requirements, in each case under circumstances that would make
it impractical or inadvisable to cause any Registration Statement (or such filings) to be used by Investor or to promptly amend or supplement
any Registration Statement contemplated by this Agreement on a post effective basis, as applicable, or (y) has experienced some other
material non-public event the disclosure of which at such time, in the good faith judgment of the Company, would materially adversely
affect the Company (each, an “Allowable Grace Period”); provided, however, that in no event shall the
Investor be suspended from selling Registrable Securities pursuant to any Registration Statement for a period that exceeds 20 consecutive
Trading Days or an aggregate of 60 days in any 365-day period; and provided, further, the Company shall not effect any such suspension
during (A) the first 10 consecutive Trading Days after the Effective Date of the particular Registration Statement or (B) the five-Trading
Day period commencing on the VWAP Purchase Date for each VWAP Purchase. Upon disclosure of such information or the termination of the
condition described above, the Company shall provide prompt notice, but in any event within one Business Day of such disclosure or termination,
to the Investor and shall promptly terminate any suspension of sales it has put into effect and shall take such other reasonable actions
to permit registered sales of Registrable Securities as contemplated in this Agreement (including as set forth in the first sentence
of Section 3(f) with respect to the information giving rise thereto unless such material, non-public information is no longer applicable).
Notwithstanding anything to the contrary contained in this Section 3(p), the Company shall cause its transfer agent to deliver DWAC Shares
to a transferee of the Investor in accordance with the terms of the Purchase Agreement in connection with any sale of Registrable Securities
with respect to which (i) the Company has made a sale to Investor and (ii) the Investor has entered into a contract for sale, and delivered
a copy of the Prospectus included as part of the particular Registration Statement to the extent applicable, in each case prior to the
Investor’s receipt of the notice of an Allowable Grace Period and for which the Investor has not yet settled.

 

    10

     

    

 

		4.	Obligations
                                            of the Investor.

 

(a)
At least five (5) Business Days prior to the first anticipated filing date of each Registration Statement (or such shorter period to
which the parties agree), the Company shall notify the Investor in writing of the information the Company requires from the Investor
with respect to such Registration Statement. It shall be a condition precedent to the obligations of the Company to complete the registration
pursuant to this Agreement with respect to the Registrable Securities of the Investor that the Investor shall furnish to the Company
such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities
held by it, as shall be reasonably required to effect and maintain the effectiveness of the registration of such Registrable Securities
and shall execute such documents in connection with such registration as the Company may reasonably request.

 

(b)
The Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of each Registration Statement hereunder, unless the Investor has notified the Company
in writing of the Investor’s election to exclude all of the Investor’s Registrable Securities from such Registration Statement.

 

(c)
The Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section
3(p) or the first sentence of 3(f), the Investor shall immediately discontinue disposition of Registrable Securities pursuant to any
Registration Statement(s) covering such Registrable Securities until the Investor’s receipt of the copies of the supplemented or
amended Prospectus contemplated by Section 3(p) or the first sentence of Section 3(f) or receipt of notice that no supplement or amendment
is required. Notwithstanding anything to the contrary in this Section 4(c), the Company shall cause its transfer agent to deliver DWAC
Shares to a transferee of the Investor in accordance with the terms of the Purchase Agreement in connection with any sale of Registrable
Securities with respect to which the Investor has entered into a contract for sale prior to the Investor’s receipt of a notice
from the Company of the happening of any event of the kind described in Section 3(p) or the first sentence of Section 3(f) and for which
the Investor has not yet settled.

 

(d)
The Investor covenants and agrees that it shall comply with the prospectus delivery and other requirements of the Securities Act as applicable
to it in connection with sales of Registrable Securities pursuant to a Registration Statement.

 

		5.	Expenses
                                            of Registration.

 

All
reasonable expenses of the Company, other than sales or brokerage commissions and fees and disbursements of counsel for, and other expenses
of, the Investor, incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without
limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel for
the Company, shall be paid by the Company.

 

    11

     

    

 

		6.	Indemnification.

 

(a)
In the event any Registrable Securities are included in any Registration Statement under this Agreement, to the fullest extent permitted
by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each of its directors, officers, stockholders,
members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding the lack of such title or any other title) and each Person, if any, who controls the Investor within
the meaning of the Securities Act or the Exchange Act and each of the directors, officers, stockholders, members, partners, employees,
agents, advisors, representatives (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
the lack of such title or any other title) of such controlling Persons (each, an “Investor Party” and collectively,
the “Investor Parties”), against any losses, obligations, claims, damages, liabilities, contingencies, judgments,
fines, penalties, charges, costs (including, without limitation, court costs, reasonable attorneys’ fees, costs of defense and
investigation), amounts paid in settlement or expenses, joint or several, (collectively, “Claims”) reasonably
incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the
foregoing by or before any court or governmental, administrative or other regulatory agency, body or the Commission, whether pending
or threatened, whether or not an Investor Party is or may be a party thereto (“Indemnified Damages”), to which
any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof)
arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement or
any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the securities
or other “Blue Sky” laws of any jurisdiction in which Registrable Securities are offered (“Blue Sky Filing”),
or the omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein
not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Prospectus (as amended or
supplemented) or in any Prospectus Supplement or the omission or alleged omission to state therein any material fact necessary to make
the statements made therein, in the light of the circumstances under which the statements therein were made, not misleading (the matters
in the foregoing clauses (i) and (ii) being, collectively, “Violations”). Subject to Section 6(e), the Company
shall reimburse the Investor Parties, promptly as such expenses are incurred and are due and payable, for any legal fees or other reasonable
expenses incurred by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained
herein, the indemnification agreement contained in this Section 6(a): (i) shall not apply to a Claim by an Investor Party arising out
of or based upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by
such Investor Party for such Investor Party expressly for use in connection with the preparation of such Registration Statement, Prospectus
or Prospectus Supplement or any such amendment thereof or supplement thereto (it being hereby acknowledged and agreed that the written
information set forth on Exhibit C attached hereto is the only written information furnished to the Company by or on behalf of
the Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement); (ii) shall not be available to the
Investor to the extent such Claim is based on a failure of the Investor to deliver or to cause to be delivered the Prospectus (as amended
or supplemented) made available by the Company (to the extent applicable), including, without limitation, a corrected Prospectus, if
such Prospectus (as amended or supplemented) or corrected Prospectus was timely made available by the Company pursuant to Section 3(d)
and then only if, and to the extent that, following the receipt of the corrected Prospectus no grounds for such Claim would have existed;
and (iii) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent
of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of the Investor Party and shall survive the transfer of any of the Registrable Securities by
the Investor pursuant to Section 9.

 

    12

     

    

 

(b)
In connection with any Registration Statement in which the Investor is participating, the Investor agrees to severally and not jointly
indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of
its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within the
meaning of the Securities Act or the Exchange Act (each, an “Company Party”), against any Claim or Indemnified
Damages to which any of them may become subject, under the Securities Act, the Exchange Act or otherwise, insofar as such Claim or Indemnified
Damages arise out of or are based upon any Violation, in each case, to the extent, and only to the extent, that such Violation occurs
in reliance upon and in conformity with written information relating to the Investor furnished to the Company by the Investor expressly
for use in connection with such Registration Statement, the Prospectus included therein or any Prospectus Supplement thereto (it being
hereby acknowledged and agreed that the written information set forth on Exhibit C attached hereto is the only written information
furnished to the Company by or on behalf of the Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement);
and, subject to Section 6(e) and the below provisos in this Section 6(b), the Investor shall reimburse a Company Party any legal or other
expenses reasonably incurred by such Company Party in connection with investigating or defending any such Claim; provided, however,
the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in Section 7 shall not
apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Investor, which
consent shall not be unreasonably withheld or delayed; and provided, further that the Investor shall be liable under this Section
6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to the Investor as a result of the applicable
sale of Registrable Securities pursuant to such Registration Statement, Prospectus or Prospectus Supplement. Such indemnity shall remain
in full force and effect regardless of any investigation made by or on behalf of such Company Party and shall survive the transfer of
any of the Registrable Securities by the Investor pursuant to Section 9.

 

(c)
Promptly after receipt by an Investor Party or Company Party (as the case may be) under this Section 6 of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Investor Party
or Company Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section
6, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to
participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to
assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Investor Party or the Company
Party (as the case may be); provided, however, an Investor Party or Company Party (as the case may be) shall have the right
to retain its own counsel with the fees and expenses of such counsel to be paid by the indemnifying party if: (i) the indemnifying party
has agreed in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume the defense of
such Claim and to employ counsel reasonably satisfactory to such Investor Party or Company Party (as the case may be) in any such Claim;
or (iii) the named parties to any such Claim (including, without limitation, any impleaded parties) include both such Investor Party
or Company Party (as the case may be) and the indemnifying party, and such Investor Party or such Company Party (as the case may be)
shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent such Investor
Party or such Company Party and the indemnifying party (in which case, if such Investor Party or such Company Party (as the case may
be) notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the indemnifying party, then
the indemnifying party shall not have the right to assume the defense thereof on behalf of the indemnified party and such counsel shall
be at the expense of the indemnifying party, provided further that in the case of clause (iii) above the indemnifying party shall
not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for all Investor Parties or Company
Parties (as the case may be). The Company Party or Investor Party (as the case may be) shall reasonably cooperate with the indemnifying
party in connection with any negotiation or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying
party all information reasonably available to the Company Party or Investor Party (as the case may be) which relates to such action or
Claim. The indemnifying party shall keep the Company Party or Investor Party (as the case may be) reasonably apprised at all times as
to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement
of any action, claim or proceeding effected without its prior written consent; provided, however, the indemnifying party
shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the
Company Party or Investor Party (as the case may be), consent to entry of any judgment or enter into any settlement or other compromise
which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Company Party or Investor Party
(as the case may be) of a release from all liability in respect to such Claim or litigation, and such settlement shall not include any
admission as to fault on the part of the Company Party. For the avoidance of doubt, the immediately preceding sentence shall apply to
Sections 6(a) and 6(b) hereof. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all
rights of the Company Party or Investor Party (as the case may be) with respect to all third parties, firms or corporations relating
to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying party within a reasonable
time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Investor Party or Company
Party (as the case may be) under this Section 6, except to the extent that the indemnifying party is materially and adversely prejudiced
in its ability to defend such action.

 

    13

     

    

 

(d)
No Person involved in the sale of Registrable Securities who is guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) in connection with such sale shall be entitled to indemnification from any Person involved in such sale
of Registrable Securities who is not guilty of fraudulent misrepresentation.

 

(e)
The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred; provided that any Person receiving any payment
pursuant to this Section 6 shall promptly reimburse the Person making such payment for the amount of such payment to the extent a court
of competent jurisdiction determines that such Person receiving such payment was not entitled to such payment.

 

(f)
The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Company
Party or Investor Party against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant
to the law.

 

		7.	Contribution.

 

To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;
provided, however: (i) no contribution shall be made under circumstances where the maker would not have been liable for
indemnification under the fault standards set forth in Section 6 of this Agreement, (ii) no Person involved in the sale of Registrable
Securities which Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) in connection
with such sale shall be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of
fraudulent misrepresentation; and (iii) contribution by any seller of Registrable Securities shall be limited in amount to the amount
of net proceeds received by such seller from the applicable sale of such Registrable Securities pursuant to such Registration Statement.
Notwithstanding the provisions of this Section 7, the Investor shall not be required to contribute, in the aggregate, any amount in excess
of the amount by which the net proceeds actually received by the Investor from the applicable sale of the Registrable Securities subject
to the Claim exceeds the amount of any damages that the Investor has otherwise been required to pay, or would otherwise be required to
pay under Section 6(b), by reason of such untrue or alleged untrue statement or omission or alleged omission.

 

		8.	Reports
                                            Under the Exchange Act.

 

With
a view to making available to the Investor the benefits of Rule 144, the Company agrees to:

 

(a)
use its commercially reasonable efforts to make and keep public information available, as those terms are understood and defined in Rule
144;

 

(b)
use its commercially reasonable efforts to file with the Commission in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements (it being understood
that nothing herein shall limit any of the Company’s obligations under the Purchase Agreement) and the filing of such reports and
other documents is required for the applicable provisions of Rule 144;

 

(c)
furnish to the Investor so long as the Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company,
if true, that it has complied with the reporting, submission and posting requirements of Rule 144 and the Exchange Act, (ii) a copy of
the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with the Commission
if such reports are not publicly available via EDGAR, and (iii) such other information as may be reasonably requested to permit the Investor
to sell such securities pursuant to Rule 144 without registration; and

 

    14

     

    

 

(d)
take such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant
to Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions
to the Company’s transfer agent as may be reasonably requested from time to time by the Investor and otherwise fully cooperate
with Investor and Investor’s broker to effect such sale of securities pursuant to Rule 144.

 

		9.	Assignment
                                            of Registration Rights.

 

Neither
the Company nor the Investor shall assign this Agreement or any of their respective rights or obligations hereunder.

 

		10.	Amendment
                                            or Waiver.

 

No
provision of this Agreement may be amended or waived by the parties from and after the date that is one (1) Trading Day immediately preceding
the date on which the Initial Registration Statement is initially filed with the Commission. Subject to the immediately preceding sentence,
no provision of this Agreement may be (i) amended other than by a written instrument signed by both parties hereto or (ii) waived other
than in a written instrument signed by the party against whom enforcement of such waiver is sought. Failure of any party to exercise
any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a
waiver thereof.

 

		11.	Miscellaneous.

 

(a)
Solely for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed
to own of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more
Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received
from such record owner of such Registrable Securities.

 

(b)
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement shall be given
in accordance with Section 10.4 of the Purchase Agreement.

 

(c)
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right
or remedy, shall not operate as a waiver thereof. The Company and the Investor acknowledge and agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that either party shall be entitled to an injunction or injunctions to prevent or cure breaches of
the provisions of this Agreement by the other party and to enforce specifically the terms and provisions hereof (without the necessity
of showing economic loss and without any bond or other security being required), this being in addition to any other remedy to which
either party may be entitled by law or equity.

 

(d)
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of New York, without giving effect to any law or rule (whether of the State of New York or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits
to the exclusive jurisdiction of the federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to
limit in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall be invalid or unenforceable
in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement
in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction. EACH PARTY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR
IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    15

     

    

 

(e)
The Transaction Documents set forth the entire agreement and understanding of the parties solely with respect to the subject matter thereof
and supersedes all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written,
solely with respect to such matters. There are no promises, undertakings, representations or warranties by either party relative to subject
matter hereof not expressly set forth in the Transaction Documents. Notwithstanding anything in this Agreement to the contrary and without
implication that the contrary would otherwise be true, nothing contained in this Agreement shall limit, modify or affect in any manner
whatsoever (i) the conditions precedent to a VWAP Purchase contained in Article VII of the Purchase Agreement or (ii) any of the Company’s
obligations under the Purchase Agreement.

 

(f)
This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors. This Agreement is
not for the benefit of, nor may any provision hereof be enforced by, any Person, other than the parties hereto, their respective successors
and the Persons referred to in Sections 6 and 7 hereof.

 

(g)
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and
plural forms thereof. The terms “including,” “includes,” “include” and words of like import shall
be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,”
“hereof” and words of like import refer to this entire Agreement instead of just the provision in which they are found.

 

(h)
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by e-mail in a “.pdf” format data file, including any electronic signature complying with the U.S.
federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall be binding
upon the signatory thereto with the same force and effect as if the signature were an original signature.

 

(i)
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(j)
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.

 

[Signature
Pages Follow]

 

    16

     

    

 

IN
WITNESS WHEREOF, Investor and the Company have caused their respective signature page to this Registration Rights Agreement to be
duly executed as of the date first written above.

 

	 	COMPANY:
	 	 
	 	CINEDIGM CORP.
	 	 
	 	By: 	/s/ Gary S. Loffredo 
	 	 	Name:	Gary Loffredo
	 	 	Title:	President, Chief Operating Officer, General Counsel and Secretary

 

    17

     

    

 

IN
WITNESS WHEREOF, Investor and the Company have caused their respective signature page to this Registration Rights Agreement to be
duly executed as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	B. RILEY PRINCIPAL CAPITAL, LLC
	 	 
	 	By: 	/s/ Daniel Shribman
	 	 	Name:	Daniel Shribman
	 	 	Title:	President

 

    18

     

    

 

EXHIBIT
A

 

FORM
OF NOTICE OF EFFECTIVENESS

OF REGISTRATION STATEMENT

 

[●]

[●]

[●]

 

Re:
Cinedigm Corp.

 

Ladies
and Gentlemen:

 

We
are counsel to Cinedigm Corp., a Delaware corporation (the “Company”), and have represented the Company in
connection with that certain Common Stock Purchase Agreement, dated October 12, 2021 (the “Purchase Agreement”),
entered into by and among the Company and the Investor named therein (the “Holder”), pursuant to which the
Company has issued and may issue to the Holder from time to time shares of the Company’s Class A common stock, par value $0.001
per share (the ”Common Stock”). Pursuant to the Purchase Agreement, the Company also has entered into
a Registration Rights Agreement, dated as of October 12, 2021, with the Holder (the “Registration Rights Agreement”),
pursuant to which the Company agreed, among other things, to register the offer and sale by the Holder of the Registrable Securities
(as defined in the Registration Rights Agreement) under the Securities Act of 1933, as amended (the “Securities Act”).
In connection with the Company’s obligations under the Registration Rights Agreement, on [●], 202[●], the Company filed
a Registration Statement on Form S-1 (File No. 333-[●]) (the “Registration Statement”) with the Securities
and Exchange Commission (the “Commission”) relating to the resale by the holder of Registrable Securities and
which names the Holder as an underwriter and a selling stockholder thereunder.

 

In
connection with the foregoing, based solely on our review of the Commission’s EDGAR website, we advise you that the Registration
Statement became effective under the Securities Act on [●], 202[●]. In addition, based solely on our review of the information
made available by the Commission at http://www.sec.gov/litigation/stoporders.shtml, we confirm that the Commission has not issued any
stop order suspending the effectiveness of the Registration Statement. To our knowledge, based solely on our participation in the conferences
mentioned above regarding the Registration Statement and our review of the information made available by the Commission at http://www.sec.gov/litigation/stoporders.shtml,
no proceedings for that purpose are pending or have been instituted or threatened by the Commission.

 

This
letter shall serve as our standing opinion to you that the shares of Common Stock included in the Registration Statement are freely transferable
by the Holder pursuant to the Registration Statement, provided the Registration Statement remains effective.

 

This
opinion letter is limited to the federal securities laws of the United States of America. We express no opinion as to matters relating
to state securities laws or Blue Sky laws.

 

We
assume no obligation to update or supplement this opinion letter to reflect any facts or circumstances which may hereafter come to our
attention with respect to the opinion and statements expressed above, including any changes in applicable law that may hereafter occur.

 

This
opinion letter is being delivered solely for the benefit of the person to whom it is addressed; accordingly, it may not be quoted, filed
with any governmental authority or other regulatory agency or otherwise circulated or utilized for any purposes without our prior written
consent.

 

	 	Very
                                            truly yours,

	 	 
	 	[ISSUER’S
    COUNSEL]

	 	 
	 	By: 	        

 

		cc:	B.
                                            Riley Principal Capital, LLC

 

    A-1

     

    

 

EXHIBIT
B

 

SELLING
STOCKHOLDER

 

This
prospectus relates to the offer and sale by B. Riley Principal Capital of up to [●] shares of common stock that have been and may
be issued by us to B. Riley Principal Capital under the Purchase Agreement. For additional information regarding the shares of common
stock included in this prospectus, see the section titled “Committed Equity Financing” above. We are registering the shares
of common stock included in this prospectus pursuant to the provisions of the Registration Rights Agreement we entered into with B. Riley
Principal Capital on October 12, 2021 in order to permit the selling stockholder to offer the shares included in this prospectus for
resale from time to time. Except for the transactions contemplated by the Purchase Agreement and the Registration Rights Agreement and
as set forth in the section titled “Plan of Distribution” in this prospectus, B. Riley Principal Capital has not had any
material relationship with us within the past three years. As used in this prospectus, the term “selling stockholder” means
B. Riley Principal Capital, LLC.

 

The
table below presents information regarding the selling stockholder and the shares of common stock that may be resold by the selling stockholder
from time to time under this prospectus. This table is prepared based on information supplied to us by the selling stockholder, and reflects
holdings as of October 12, 2021. The number of shares in the column “Maximum Number of Shares of Common Stock to be Offered Pursuant
to this Prospectus” represents all of the shares of common stock being offered for resale by the selling stockholder under this
prospectus. The selling stockholder may sell some, all or none of the shares being offered for resale in this offering. We do not know
how long the selling stockholder will hold the shares before selling them, and we are not aware of any existing arrangements between
the selling stockholder and any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the shares
of our common stock being offered for resale by this prospectus.

 

Beneficial
ownership is determined in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes shares of common
stock with respect to which the selling stockholder has sole or shared voting and investment power. The percentage of shares of common
stock beneficially owned by the selling stockholder prior to the offering shown in the table below is based on an aggregate of 169,320,196
shares of our common stock outstanding on October 12, 2021. Because the purchase price to be paid by the selling stockholder for shares
of common stock, if any, that we may elect to sell to the selling stockholder in one or more VWAP Purchases from time to time under the
Purchase Agreement will be determined on the applicable VWAP Purchase Dates for such VWAP Purchases, the actual number of shares of common
stock that we may sell to the selling stockholder under the Purchase Agreement may be fewer than the number of shares being offered for
resale under this prospectus. The fourth column assumes the resale by the selling stockholder of all of the shares of common stock being
offered for resale pursuant to this prospectus.

 

    B-2

     

    

 

	Name
    of Selling Stockholder	 	Number
    of Shares of

    Common Stock Owned

    Prior to Offering	 	Maximum
    Number of

    Shares of Common Stock

    to be Offered Pursuant to 

    this Prospectus	 	Number
    of Shares of

    Common Stock Owned

    After Offering	 
	 	 	Number(1)	 	 	Percent(2)	 	 	 	Number(3)	 	 	Percent(2)	 
	B. Riley Principal
    Capital, LLC(4)	 	 	210,084	 	 	*	 	[●]	 	 	0	 	 	 	--	 

 

 

		*	Represents
                                            beneficial ownership of less than 1% of the outstanding shares of our common stock.

 

		(1)	Represents
                                            the 210,084 shares of common stock we issued to B. Riley Principal Capital on October 12,
                                            2021 as Commitment Shares in consideration for entering into the Purchase Agreement with
                                            us. In accordance with Rule 13d-3(d) under the Exchange Act, we have excluded from the number
                                            of shares beneficially owned prior to the offering all of the shares that B. Riley Principal
                                            Capital may be required to purchase under the Purchase Agreement, because the issuance of
                                            such shares is solely at our discretion and is subject to conditions contained in the Purchase
                                            Agreement, the satisfaction of which are entirely outside of B. Riley Principal Capital’s
                                            control, including the registration statement that includes this prospectus becoming and
                                            remaining effective. Furthermore, the VWAP Purchases of common stock under the Purchase Agreement
                                            are subject to certain agreed upon maximum amount limitations set forth in the Purchase Agreement.
                                            Also, the Purchase Agreement prohibits us from issuing and selling any shares of our common
                                            stock to B. Riley Principal Capital to the extent such shares, when aggregated with all other
                                            shares of our common stock then beneficially owned by B. Riley Principal Capital, would cause
                                            B. Riley Principal Capital’s beneficial ownership of our common stock to exceed the
                                            4.99% Beneficial Ownership Cap. The Purchase Agreement also prohibits us from issuing or
                                            selling shares of our common stock under the Purchase Agreement in excess of the 19.99% Exchange
                                            Cap, unless we obtain stockholder approval to do so, or unless the average price per share
                                            paid by B. Riley Principal Capital for all shares of common stock purchased by B. Riley Principal
                                            Capital under the Purchase Agreement equals or exceeds $2.3949 per share, in which case the
                                            Exchange Cap limitation would no longer apply under applicable Nasdaq rules. Neither the
                                            Beneficial Ownership Limitation nor the Exchange Cap (to the extent applicable under Nasdaq
                                            rules) may be amended or waived under the Purchase Agreement.

 

		(2)	Applicable
                                            percentage ownership is based on 169,320,196 shares of our common stock outstanding as of
                                            October 12, 2021.

 

		(3)	Assumes
                                            the sale of all shares being offered pursuant to this prospectus.

 

		(4)	The
                                            business address of B. Riley Principal Capital, LLC (“BRPC”) is 11100 Santa Monica
                                            Blvd., Suite 800, Los Angeles, CA 90025. BRPC’s principal business is that of a private
                                            investor. Daniel Shribman and Nick Capuano are the President and Chief Investment Officer,
                                            respectively, of BRPC. The sole member of BRPC is B. Riley Principal Investments, LLC (“BRPI”),
                                            which is an indirect subsidiary of B. Riley Financial, Inc. (“BRF”). Mr. Shribman
                                            is the President of BRPI and the Chief Investment Officer of BRF. Mr. Shribman has sole voting
                                            power and sole investment power over securities beneficially owned, directly, by BRPC, and
                                            therefore Mr. Shribman may be deemed to beneficially own, indirectly, the securities beneficially
                                            owned, directly, by BRPC. The sole voting and investment powers of Mr. Shribman over securities
                                            beneficially owned directly by BRPC are exercised independently from all other direct and
                                            indirect subsidiaries of BRF, and the voting and investment powers over securities beneficially
                                            owned directly or indirectly by all other direct and indirect subsidiaries of BRF are exercised
                                            independently from BRPC. We have been advised that neither BRPI nor BRPC is a member of the
                                            Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer. The foregoing
                                            should not be construed in and of itself as an admission by Mr. Shribman as to beneficial
                                            ownership of the securities beneficially owned, directly, by BRPC.

 

    B-3

     

    

 

PLAN
OF DISTRIBUTION

 

The
shares of common stock offered by this prospectus are being offered by the selling stockholder, B. Riley Principal Capital, LLC.  The
shares may be sold or distributed from time to time by the selling stockholder directly to one or more purchasers or through brokers,
dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing
market prices, at negotiated prices, or at fixed prices, which may be changed. The sale of the shares of our common stock offered by
this prospectus could be effected in one or more of the following methods:

 

		●	ordinary
                                            brokers’ transactions;

 

		●	transactions
                                            involving cross or block trades; 

 

		●	through
                                            brokers, dealers, or underwriters who may act solely as agents; 

 

		●	“at
                                            the market” into an existing market for our common stock; 

 

		●	in
                                            other ways not involving market makers or established business markets, including direct
                                            sales to purchasers or sales effected through agents; 

 

		●	in
                                            privately negotiated transactions; or 

 

		●	any
                                            combination of the foregoing.

 

In
order to comply with the securities laws of certain states, if applicable, the shares may be sold only through registered or licensed
brokers or dealers. In addition, in certain states, the shares may not be sold unless they have been registered or qualified for sale
in the state or an exemption from the state’s registration or qualification requirement is available and complied with.

 

B.
Riley Principal Capital is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act.

 

B.
Riley Principal Capital has informed us that it intends to use one or more registered broker-dealers (one of which is an affiliate of
B. Riley Principal Capital) to effectuate all sales, if any, of our common stock that it may acquire from us pursuant to the Purchase
Agreement.  Such sales will be made at prices and at terms then prevailing or at prices related to the then current market price.
 Each such registered broker-dealer will be an underwriter within the meaning of Section 2(a)(11) of the Securities Act.  B.
Riley Principal Capital has informed us that each such broker-dealer (excluding any broker-dealer that is an affiliate of B. Riley Principal
Capital), may receive commissions from B. Riley Principal Capital for executing such sales for B. Riley Principal Capital and, if so,
such commissions will not exceed customary brokerage commissions.

 

Brokers,
dealers, underwriters or agents participating in the distribution of the shares of our common stock offered by this prospectus may receive
compensation in the form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent,
of the shares sold by the selling stockholder through this prospectus. The compensation paid to any such particular broker-dealer by
any such purchasers of shares of our common stock sold by the selling stockholder may be less than or in excess of customary commissions.
 Neither we nor the selling stockholder can presently estimate the amount of compensation that any agent will receive from any purchasers
of shares of our common stock sold by the selling stockholder.

 

    B-4

     

    

 

We
know of no existing arrangements between the selling stockholder or any other stockholder, broker, dealer, underwriter or agent relating
to the sale or distribution of the shares of our common stock offered by this prospectus.

 

We
may from time to time file with the SEC one or more supplements to this prospectus or amendments to the registration statement of which
this prospectus forms a part to amend, supplement or update information contained in this prospectus, including, if and when required
under the Securities Act, to disclose certain information relating to a particular sale of shares offered by this prospectus by the selling
stockholder, including with respect to any compensation paid or payable by the selling stockholder to any brokers, dealers, underwriters
or agents that participate in the distribution of such shares by the selling stockholder, and any other related information required
to be disclosed under the Securities Act.

 

We
will pay the expenses incident to the registration under the Securities Act of the offer and sale of the shares of our common stock covered
by this prospectus by the selling stockholder.

 

As
consideration for its irrevocable commitment to purchase our common stock under the Purchase Agreement, we issued to B. Riley Principal
Capital 210,084 shares of our common stock as Commitment Shares upon execution of the Purchase Agreement and the Registration Rights
Agreement. In addition, we have agreed to reimburse B. Riley Principal Capital up to $50,000 for the fees and disbursements of its counsel
in connection with the transactions contemplated by the Purchase Agreement and the Registration Rights Agreement.

 

We
also have agreed to indemnify B. Riley Principal Capital and certain other persons against certain liabilities in connection with the
offering of shares of our common stock offered hereby, including liabilities arising under the Securities Act or, if such indemnity is
unavailable, to contribute amounts required to be paid in respect of such liabilities.  B. Riley Principal Capital has agreed to
indemnify us against liabilities under the Securities Act that may arise from certain written information furnished to us by B. Riley
Principal Capital specifically for use in this prospectus or, if such indemnity is unavailable, to contribute amounts required to be
paid in respect of such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to
our directors, officers, and controlling persons, we have been advised that in the opinion of the SEC this indemnification is against
public policy as expressed in the Securities Act and is therefore, unenforceable.

 

We
estimate that the total expenses for the offering will be approximately $[●].

 

B.
Riley Principal Capital has represented to us that at no time prior to the date of the Purchase Agreement has B. Riley Principal Capital
engaged in or effected, in any manner whatsoever, directly or indirectly, for its own account or for the account of any of its affiliates,
any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our common stock or any hedging transaction,
which establishes a net short position with respect to our common stock.  B. Riley Principal Capital has agreed that during the
term of the Purchase Agreement, none of B. Riley Principal Capital, its officers, its sole member, or any entity managed or controlled
by B. Riley Principal Capital or its sole member, will enter into or effect, directly or indirectly, any of the foregoing transactions
for its own account or for the account of any other such person or entity.

 

    B-5

     

    

 

We
have advised the selling stockholder that it is required to comply with Regulation M promulgated under the Exchange Act. With certain
exceptions, Regulation M precludes the selling stockholder, any affiliated purchasers, and any broker-dealer or other person who participates
in the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the
subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order
to stabilize the price of a security in connection with the distribution of that security. All of the foregoing may affect the marketability
of the securities offered by this prospectus.

 

This
offering will terminate on the date that all shares of our common stock offered by this prospectus have been sold by the selling stockholder.

 

Our
common stock is currently listed on The Nasdaq Global Market under the symbol “CIDM”.

 

One
or more affiliates of B. Riley Principal Capital have provided, currently provide and/or from time to time in the future may provide
various investment banking and other financial services for us that are unrelated to the transactions contemplated by the Purchase Agreement
and the offering of shares for resale by B. Riley Principal Capital to which this prospectus relates, for which investment banking and
other financial services they have received and may continue to receive customary fees, commissions and other compensation from us, apart
from the fees, discounts and other compensation that B. Riley Principal Capital has received and may continue to receive from us in connection
with the transactions contemplated by the Purchase Agreement.

 

    B-6

     

    

 

EXHIBIT
C

 

The
business address of B. Riley Principal Capital, LLC (“BRPC”) is 11100 Santa Monica Blvd., Suite 800, Los Angeles, CA 90025.
BRPC’s principal business is that of a private investor. Daniel Shribman and Nick Capuano are the President and Chief Investment
Officer, respectively, of BRPC. The sole member of BRPC is B. Riley Principal Investments, LLC (“BRPI”), which is an indirect
subsidiary of B. Riley Financial, Inc. (“BRF”). Mr. Shribman is the President of BRPI and the Chief Investment Officer of
BRF. Mr. Shribman has sole voting power and sole investment power over securities beneficially owned, directly, by BRPC, and therefore
Mr. Shribman may be deemed to beneficially own, indirectly, the securities beneficially owned, directly, by BRPC. The sole voting and
investment powers of Mr. Shribman over securities beneficially owned directly by BRPC are exercised independently from all other direct
and indirect subsidiaries of BRF, and the voting and investment powers over securities beneficially owned directly or indirectly by all
other direct and indirect subsidiaries of BRF are exercised independently from BRPC. We have been advised that neither BRPI nor BRPC
is a member of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer. The foregoing should not be construed
in and of itself as an admission by Mr. Shribman as to beneficial ownership of the securities beneficially owned, directly, by BRPC.

 

 

 

C-1Exhibit 10.1

 

FARMLAND PARTNERS INC.

EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT
(this “Agreement”) dated as of October 9, 2021 (the “Effective Date”), is entered into
between Farmland Partners Inc., a Maryland corporation (the “Farmland”), and Farmland Partners Operating Partnership,
LP, a Delaware limited partnership (the “Operating Partnership” and, together with Farmland, the “Company”),
each with its principal place of business at 4600 S. Syracuse Street, Suite 1450, Denver, CO 80237, and James Gilligan residing at
the address on file with the Company (the “Employee”).

 

W I T N E S S E T H

 

WHEREAS, the Company
and Employee wish to enter into an employment agreement pursuant to mutually agreeable terms.

 

NOW, THEREFORE, in
consideration of the foregoing, of the mutual promises contained herein and of other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

 

		1.	POSITION AND DUTIES.

 

(a)           During
the Employment Term (as defined in Section 2 hereof), the Employee shall serve as the Chief Financial Officer of the Company.
In this capacity, the Employee shall have the duties, authorities and responsibilities as are required by the Employee’s position
commensurate with the duties, authorities and responsibilities of persons in similar capacities in similarly sized companies, and such
other duties, authorities and responsibilities as may reasonably be assigned to the Employee as the Chief Executive Officer of the Company
shall designate from time to time that are not inconsistent with the Employee’s position with the Company and that are consistent
with the bylaws of the Company and the amended and restated agreement of limited partnership of the Operating Partnership as it may be
further amended from time to time, including, but not limited to, managing the affairs of the Company. The Employee’s principal
place of employment with the Company shall be in Denver, Colorado, provided that the Employee understands and agrees that the Employee
may be required to travel from time to time to other locations for business purposes. The Employee shall report directly to the Chief
Executive Officer of the Company.

 

(b)           During
the Employment Term, the Employee shall devote substantially all of the Employee’s business time, energy, business judgment, knowledge
and skill and the Employee’s best efforts to the performance of the Employee’s duties with the Company, provided that
the foregoing shall not prevent the Employee from (i) serving on the boards of directors of non- profit organizations, (ii) participating
in charitable, civic, educational, professional, community or industry affairs, and (iii) managing the Employee’s personal
investments and/or personal business as necessary, so long as such activities in the aggregate do not interfere or conflict with the Employee’s
duties hereunder or create a potential business or fiduciary conflict.

 

     

     

    

 

2.            EMPLOYMENT
TERM. The Company agrees to employ the Employee pursuant to the terms of this Agreement, and
the Employee agrees to be so employed, until December 13, 2022 (the “Initial Term”) commencing as of the Effective
Date. Commencing with the last day of the Initial Term, and on each subsequent anniversary of such date, the term of this Agreement shall
be automatically extended for successive one-year periods, provided, however, that either party hereto may elect not to
extend this Agreement by giving written notice to the other party at least sixty (60) days prior to any such anniversary date. Notwithstanding
the foregoing, the Employee’s employment hereunder may be earlier terminated in accordance with Section 7 hereof, subject
to Section 8 hereof. The period of time between the Effective Date and the end of the Initial Term and any successor terms
(or earlier upon a termination of the Employee’s employment hereunder) shall be referred to herein as the “Employment Term.”
If the Employee’s employment continues following any expiration of the Employment Term due to either party giving notice not to
extend this Agreement, such employment will be entirely “at- will,” and will not be covered by this Agreement (except for
the applicable restrictive covenant provisions, which are intended to survive expiration of the Agreement in all cases).

 

3.            BASE
SALARY. The Company agrees to pay the Employee a base salary at an annual rate of not less than
$300,000, payable in accordance with the regular payroll practices of the Company, but not less frequently than monthly. The Employee’s
Base Salary shall be subject to annual review by the Board of Directors of Farmland (the “Board”) (or a committee thereof),
and may be adjusted from time to time by the Board or the Compensation Committee of the Board (the “Compensation Committee”)
in its sole discretion. The base salary as determined herein and adjusted from time to time shall constitute “Base Salary”
for purposes of this Agreement.

 

4.           ANNUAL
BONUS. During the Employment Term, the Employee shall be eligible to receive an annual discretionary
incentive payment under the Company’s annual bonus plan as may be in effect from time to time (the “Annual Bonus”)
based upon the attainment of one or more pre-established performance goals and/or such other criteria as may be established by the Board
or the Compensation Committee in its sole discretion.

 

5.            EQUITY
AWARDS. The Employee shall be considered to receive equity and other long-term incentive awards
(including long-term incentive units in the Operating Partnership) under any applicable plan adopted by the Company during the Employment
Term pursuant to a written agreement (the “Equity Award Agreement”).

 

 6.            EMPLOYEE BENEFITS.

 

(a)           BENEFIT
PLANS. During the Employment Term, the Employee shall be entitled to participate in any employee benefit plan that the Company has
adopted or may adopt, maintain or contribute to for the benefit of its employees generally, subject to satisfying the applicable eligibility
requirements, except to the extent such plans are duplicative of the benefits otherwise provided hereunder. The Employee’s participation
will be subject to the terms of the applicable plan documents and generally applicable Company policies. Notwithstanding the foregoing,
the Company may modify or terminate any employee benefit plan at any time.

 

    2

     

    

 

(b)           VACATIONS.
During the Employment Term, the Employee shall be entitled to three weeks paid vacation per calendar year (as prorated for partial
years) in accordance with the Company’s policy on accrual and use applicable to employees as in effect from time to time.

 

(c)         BUSINESS
AND ENTERTAINMENT EXPENSES. Upon presentation of reasonable substantiation and documentation as the Company may specify from time
to time, the Employee shall be reimbursed in accordance with the Company’s expense reimbursement policy for all reasonable out-of-pocket
business and entertainment expenses incurred and paid by the Employee during the Employment Term and in connection with the performance
of the Employee’s duties hereunder.

 

7.            TERMINATION.
The Employee’s employment and the Employment Term shall terminate on the first of the following to occur:

 

(a)          DISABILITY.
Upon termination of Employee’s employment by the Company due to Employee’s Disability. For purposes of this Agreement,
 “Disability” shall be defined as the inability of the Employee to have performed the Employee’s material duties
hereunder due to a physical or mental injury, infirmity or incapacity for one hundred eighty (180) days (including weekends and holidays)
in any 365-day period as determined by the Board in its reasonable discretion. The Company shall provide at least ten (10) days’
prior written notice of any termination due to Employee’s Disability.

 

 (b)           DEATH. Automatically upon the date of death of the Employee.

 

(c)           CAUSE. Upon
termination of Employee’s employment by the Company for Cause. “Cause” shall mean:

 

(i)            Employee’s
continued failure to substantially perform duties for reasons other than Disability, or gross negligence or willful misconduct in connection
with the performance of the Employee’s duties to the Company;

 

 (ii)           Employee’s conviction or plea of guilty or nolo contendere of a felony;

 

(iii)          Employee’s
conviction of any other criminal offense involving an act of dishonesty intended to result in substantial personal enrichment of Employee
at the expense of the Company or an affiliate of the Company; or

 

(iv)          Employee’s
material breach of any Company policy or term of this Agreement or any other employment, consulting or other services, confidentiality,
intellectual property or non-competition agreements, if any, between the Employee and the Company or an affiliate of the Company.

 

    3

     

    

 

Any determination of Cause by the Company
will be made by a resolution approved by a majority of the members of the Board, provided that no such determination may be
made until the Employee has been given written notice detailing the specific Cause event, an opportunity to appear before the full
Board with legal counsel, and a period of thirty (30) days following receipt of such notice to cure such event (if susceptible to
cure) to the satisfaction of the Board. Notwithstanding anything to the contrary contained herein, the Employee’s right to
cure and appear before the full Board with legal counsel as set forth in the preceding sentence shall not apply if there are
habitual or repeated breaches by the Employee. The Company shall provide the Employee with a written notice detailing the specific
circumstances alleged to constitute Cause within ninety (90) days after the first occurrence of such circumstances (or, if later,
the date the Company first becomes aware, or reasonably should have become aware, of such circumstances). The failure by the
Company to provide written notice in detail of the circumstances constituting “Cause” within the time period set forth
in the preceding sentence shall result in the Company being deemed not to have terminated employment for Cause and to have
irrevocably waived any claim of such circumstances constituting Cause under this Agreement.

 

(d)          WITHOUT
CAUSE. Upon termination by the Company of the Employee’s employment without Cause (other than for Disability).

 

(e)           GOOD
REASON. Upon termination by the Employee for Good Reason. “Good Reason” shall mean the occurrence of any of the
following events without the express written consent of the Employee, unless such events are fully corrected in all material respects
by the Company within thirty (30) days following written notification by the Employee to the Company of the occurrence of one of the following:

 

(i)            material diminution in the Employee’s
Base Salary or the Employee’s Total Compensation is less than $500,000;

 

(ii)           material
diminution in the Employee’s duties, authorities or responsibilities (other than temporarily while physically or mentally incapacitated
or as required by applicable law); or

 

 (iii)          the Company’s material breach of the terms of this Agreement.

 

The Employee shall provide
the Company with a written notice detailing the specific circumstances alleged to constitute Good Reason within ninety (90) days after
an occurrence of such circumstances that the Employee knows or reasonably should have known to constitute Good Reason, and actually terminate
employment within thirty (30) days following the expiration of the Company’s thirty (30)-day cure period described above. The
failure by the Employee to provide written notice in detail of the circumstances constituting “Good Reason” within the time
period set forth in the preceding sentence shall result in the Employee being deemed not to have terminated employment for Good Reason
and to have irrevocably waived any claim of such circumstances constituting Good Reason under this Agreement.

 

(f)            WITHOUT
GOOD REASON. Upon the Employee’s voluntary termination of employment without Good Reason. The Employee shall provide at least
thirty (30) days’ prior written notice of any termination without Good Reason. The Company may, in its sole discretion, make the
termination effective earlier than the termination date set forth in the notice.

 

(g)           EXPIRATION
OF EMPLOYMENT TERM; NON-EXTENSION OF AGREEMENT. Upon the expiration of the Employment Term due to a non-extension of the Agreement
by the Company or the Employee pursuant to the provisions of Section 2 hereof.

 

    4

     

    

 

		8.	CONSEQUENCES OF TERMINATION.

 

(a)           DEATH. In
the event that the Employee’s employment and the Employment Term end on account of the Employee’s death, the Employee or
the Employee’s estate, as the case may be, shall be entitled to a lump sum payment of the following within sixty (60) days following
termination of employment, or such earlier date as may be required by applicable law:

 

 (i)         any unpaid Base Salary through the termination date;

 

 (ii)        any Annual Bonus earned and accrued but unpaid;

 

(iii)       any accrued but unused vacation time in
accordance with Company policy; and

 

(iv)      reimbursement for any unreimbursed business expenses incurred through the termination date (collectively, Sections 8(a)(i) through
8(a)(iv) hereof shall be hereafter referred to as the “Accrued Benefits”).

 

(b)           DISABILITY. In the event that
the Employee’s employment and/or Employment Term ends on account of the Employee’s Disability, the Company shall pay or
provide the Employee with the following:

 

 (i)        the Accrued Benefits; and

 

(ii)       subject
to (A) the Employee’s timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of
1985, as amended (“COBRA”) and (B) the Employee’s continued compliance with the obligations in Sections
10 and 11 hereof, Employee shall be reimbursed for the amount equal to the COBRA continuation coverage premiums paid by the
Employee that is required for coverage of the Employee (or his eligible dependents) under the Company’s major medical group health
plan, for a period of eighteen (18) months, or, if less, until the Employee or his eligible dependents are no longer entitled to such
COBRA coverage (the “Continued Coverage Period”), provided, that if at any time the Company determines that
its payment of Employee’s premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of
the Internal Revenue Code of 1986, as amended (the “Code”), or any statute or regulation of similar effect (including
but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation
Act), then in lieu of providing the premiums described above, the Company will instead pay a fully taxable monthly cash payment in an
amount such that, after payment by Employee of all taxes on such payment, Employee retains an amount equal to the applicable premiums
for such month, with such monthly payment being made on the last day of each month for the remainder of the Continued Coverage Period.

 

(c)           TERMINATION
FOR CAUSE OR WITHOUT GOOD REASON OR AS A RESULT OF EMPLOYEE NON-EXTENSION OF THIS AGREEMENT. If the Employee’s employment and
the Employment Term are terminated (x) by the Company for Cause, (y) by the Employee without Good Reason, or (z) as a result
of the Employee’s non- extension of the Employment Term as provided in Section 2 hereof, the Company shall pay to the
Employee the Accrued Benefits.

 

    5

     

    

 

(d)           TERMINATION
WITHOUT CAUSE OR FOR GOOD REASON; OR TERMINATION AS A RESULT OF COMPANY NON-EXTENSION OF THIS AGREEMENT. If the Employee’s employment
and the Employment Term are terminated (x) by the Company other than for Cause (other than death or Disability) or by the Employee
for Good Reason or (y) as a result of the Company’s non-extension of the Employment Term as provided in Section 2
hereof and Employee was willing and able to remain employed, the Company shall pay or provide the Employee with the following:

 

 (i)            the Accrued Benefits;

 

(ii)           subject
to the Employee’s continued compliance with the obligations in Sections 10 and 11 hereof, an amount equal to two (2) times
the sum of (A) the Base Salary in effect on the termination date, (B) the average of the three (3) most recent Annual Bonuses
earned by the Employee (regardless of whether such amount was paid out on a current basis or deferred), plus (C) the average Equity
Award Value (as defined below) of the three (3) most recent Annual Grants (as defined below) made to the Employee by the Company,
paid in full in a lump sum within sixty (60) days after the Date of Termination; provided, however, that to the extent required
by Section 409A, if the sixty (60) day period begins in one calendar year and ends in a second calendar year, payment shall be made
in the second calendar year.

 

(iii)          subject
to (A) the Employee’s timely election of continuation coverage under COBRA and (B) the Employee’s continued compliance
with the obligations in Sections 10 and 11 hereof, Employee shall be reimbursed for the amount equal to the COBRA continuation
coverage premiums paid by the Employee that is required for coverage of the Employee (or his eligible dependents) under the Company’s
major medical group health plan, for the Continued Coverage Period, provided, that if at any time the Company determines that its
payment of Employee’s premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of
the Code, or any statute or regulation of similar effect (including but not limited to the 2010 Patient Protection and Affordable Care
Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of providing the premiums described above, the
Company will instead pay a fully taxable monthly cash payment in an amount such that, after payment by Employee of all taxes on such payment,
Employee retains an amount equal to the applicable premiums for such month, with such monthly payment being made on the last day of each
month for the remainder of the Continued Coverage Period; and

 

(iv)          all
of the Employee’s equity-based awards that are outstanding on the termination date shall immediately become fully vested and, as
applicable, exercisable, without any action by the Board or Compensation Committee; provided, that to the extent an award is intended
to qualify as performance-based compensation for purposes of Internal Revenue Code Section 162(m), such award shall not vest as a
result of the termination of the Employee’s employment and shall, instead, remain outstanding after such termination and shall be
subject to the terms and conditions of the applicable award agreement and plan document (other than continued employment).

 

Payments and benefits provided in this Section 8(d) shall
be in lieu of any termination or severance payments or benefits for which the Employee may be eligible under any of the plans,
policies or programs of the Company or under the Worker Adjustment Retraining Notification Act of 1988 or any similar state statute
or regulation.

 

    6

     

    

 

(e)           CODE
SECTION 280G. If the Employee is a “disqualified individual,” as defined in Code Section 280G(c), then,
notwithstanding any other provision of this Agreement or of any other agreement, contract, or understanding heretofore or hereafter
entered into by the Employee with the Company (an “Other Agreement”), and notwithstanding any formal or
informal plan or other arrangement for the direct or indirect provision of compensation to the Employee (including groups or classes
of employees or beneficiaries of which the Employee is a member), whether or not such compensation is deferred, is in cash or
equity, or is in the form of a benefit to or for the Employee (a “Benefit Arrangement”), any right to exercise,
vesting, payment or benefit to the Employee under this Agreement, any Other Agreement and/or any Benefit Arrangement shall be
reduced or eliminated:

 

(i)            to
the extent that such right to exercise, vesting, payment, or benefit, taking into account all other rights, payments, or benefits to or
for the Employee under this Agreement, all Other Agreements, and all Benefit Arrangements, would cause any exercise, vesting, payment
or benefit to the Employee under this Agreement to be considered a “parachute payment” within the meaning of Code Section 280G(b)(2) as
then in effect (a “Parachute Payment”); and

 

(ii)            if,
as a result of receiving such Parachute Payment, the aggregate after-tax amounts received by the Employee from the Company under this
Agreement, all Other Agreements, and all Benefit Arrangements would be less than the maximum after-tax amount that would be received by
the Employee if reduced or eliminated so that no such payment or benefit would be considered a Parachute Payment; such determination to
be made by an accounting firm selected and paid for by the Company.

 

The Company shall accomplish such reduction by
first reducing or eliminating any cash payments (with the payments to be made furthest in the future being reduced first), then by reducing
or eliminating any accelerated vesting of performance awards, then by reducing or eliminating any accelerated vesting of options or stock
appreciation rights, then by reducing or eliminating any accelerated vesting of restricted stock or stock units, then by reducing or eliminating
any other remaining Parachute Payments. If there is any question as to the ordering of any reduction pursuant to this paragraph, the accounting
firm selected by the Company shall determine the order in which amounts shall be reduced.

 

(f)            OTHER
OBLIGATIONS. Upon any termination of the Employee’s employment with the Company, unless otherwise specified in a written agreement
between the Company and the Employee, the Employee shall be deemed to have resigned from the Board and any other position as an officer,
director or fiduciary of the Company and its affiliates, and shall take any and all actions reasonably requested by the Company to effectuate
the foregoing.

 

    7

     

    

 

(g)           EXCLUSIVE
REMEDY. The amounts payable to the Employee following termination of employment and the Employment Term hereunder pursuant to Sections
7, 8 and 9 hereof shall be in full and complete satisfaction of the Employee’s rights under this Agreement
and any other claims that the Employee may have in respect of the Employee’s employment with the Company or any of its
affiliates, and the Employee acknowledges that such amounts are fair and reasonable, and are the Employee’s sole and exclusive
remedy, in lieu of all other remedies at law or in equity, with respect to the termination of the Employee’s employment
hereunder or any breach of this Agreement; provided, however, that notwithstanding anything to the contrary in this Agreement,
nothing in this Agreement shall restrict Employee from seeking remedies at law or in equity in connection with disputes relating to
the reason for any termination of the Employee’s employment hereunder for Cause or without Good Reason.

 

9.            CHANGE
IN CONTROL. If a Change in Control occurs on or before the date of a termination of the Employee’s
employment, subject to the Employee’s continued compliance with the obligations in Sections 10 and 11 hereof, the Company shall
pay and provide the compensation and benefits described in Sections 8(d)(ii) and (iv) upon the closing of the Change in Control,
and the Employee shall have no further right to receive any amounts pursuant to Section 8(d)(ii) or (iv). For avoidance of doubt,
the Employee shall retain the right to receive the amounts set forth in Section 8(d)(i) and (iii) in the event of a termination
described in Section 8(d) that occurs during the Employment Term on or after the date of the Change in Control.

 

For purposes of Section 8(d)(ii)(B),
in the event that the Employee’s termination (or with respect to Section 9, a Change in Control) occurs prior to the end of
the completion of three (3) Company fiscal years during the Employment Term, then the amount in Section 8(d)(ii)(B) shall
be determined by using the Employee’s Annual Bonus opportunity for any such fiscal year not yet completed (as determined in good
faith by the Compensation Committee), together with Annual Bonus actually earned by the Executive for the fiscal year completed during
the Employment Term (if any), annualized for any such partial fiscal year.

 

For purposes of Section 8(d)(ii)(C),
in the event that the Employee’s termination (or with respect to Section 9, a Change in Control) occurs prior to the Executive
receiving three (3) Annual Grants, then the amount in Section 8(d)(ii)(C) shall be determined based on the Equity
Award Value of Annual Grants (if any) made to the Employee during the Employment Term prior to the Employee’s termination (or with
respect to Section 9, the Change in Control).

 

For purposes of this Agreement:

 

“Annual Grant”
means the grant of equity-based awards that constitute a component of a given year’s annual compensation package and shall not include
any isolated, one-off or non- recurring grant outside of the Employee’s annual compensation package, such as (but not limited to)
an initial hiring award, a retention award, an outperformance award or other similar award, in any event, as determined in the sole discretion
of the Board or the Compensation Committee.

 

“Change in Control” means:

 

(i)            any
 “person” as such term is used in Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”) (other than Farmland, any trustee or other fiduciary holding securities under any
employee benefit plan of Farmland or any corporation owned, directly or indirectly, by the stockholders of Farmland in substantially
the same proportion as their ownership of stock of Farmland), is or becomes the “beneficial owner” (as defined in
Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of Farmland representing 50% or more of the combined
voting power of Farmland’s then outstanding voting securities;

 

    8

     

    

 

(ii)           a
change in the composition of the Board occurring within a twelve (12) month period, as a result of which fewer than a majority of the
directors are Incumbent Directors. “Incumbent Directors” means directors who were members of the Board on the Effective
Date or who were nominated or elected as directors subsequent to the Effective Date by at least a majority of the directors who were Incumbent
Directors at the time of such nomination or election or whose election to the Board was recommended or endorsed by at least a majority
of the directors who were Incumbent Directors at the time of such nomination or election; provided, however, that no director whose
election to the Board was the result of an actual or threatened election contest shall be an Incumbent Director for purposes of this Agreement;

 

(iii)          the
consummation of a merger or consolidation of Farmland with any other entity or approve the issuance of voting securities in connection
with a merger or consolidation of Farmland (or any direct or indirect subsidiary thereof) pursuant to applicable exchange requirements,
other than (A) a merger or consolidation which would result in the voting securities of Farmland outstanding immediately prior thereto
continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving or parent entity)
at least 50.1% of the combined voting power of the voting securities of Farmland or such surviving or parent entity outstanding immediately
after such merger or consolidation or (B) a merger or consolidation effected to implement a recapitalization of Farmland (or similar
transaction) in which no “person” (as defined above) is or becomes the beneficial owner, directly or indirectly, of securities
of Farmland representing 50% or more of either of the then outstanding shares of common stock or the combined voting power of Farmland’s
then outstanding voting securities; or

 

(iv)          the
consummation of the sale or disposition by Farmland of all or substantially all of its assets (or any transaction or series of
transactions within a period of twenty-four (24) months ending on the date of the last sale or disposition having a similar effect)
(a) to any “person” as such term is used in Section 13(d) and 14(d) of the Exchange Act (other any
trustee or other fiduciary holding securities under any employee benefit plan of Farmland or any corporation owned, directly or
indirectly, by the stockholders of Farmland in substantially the same proportion as their ownership of stock of Farmland) or (b) pursuant
to a formal or informal plan of liquidation or dissolution (or similar arrangement) that was approved by the Board or the
Company’s stockholders. For purposes of this paragraph, “all or substantially all” of Farmland’s assets
shall mean 80% or more of Farmland’s assets measured by the value of Farmland’s assets on the date of its balance sheet
most recently filed with the Securities and Exchange Commission at the time of action by the Board or the Company’s
stockholders, as applicable.

 

“Equity Award
Value” means (x) with respect to options and stock appreciation rights, the grant date fair value, as computed in
accordance with FASB Accounting Standards Codification Topic 718, Compensation — Stock Compensation (or any successor
accounting standard), and (y) with respect to equity-based awards other than options and stock appreciation rights, the product
of (1) the number of shares or units subject to such award, times (2) the “fair market value” of a share of
Farmland’s common stock on the date of grant as determined under the plan under which such award was granted.

 

    9

     

    

 

“Total Compensation”
means the sum of the Employee’s Base Salary, Annual Bonus earned during the calendar year, and the Equity Award Value of the equity
awards granted to the Employee during the calendar year.

 

10.          RELEASE.
Any and all amounts payable and benefits or additional rights provided pursuant to this Agreement
beyond the Accrued Benefits shall only be payable if the Employee delivers to the Company and does not revoke a general release of claims
in favor of the Company in substantially the form attached on Exhibit A hereto. Such release shall be executed and delivered
(and no longer subject to revocation, if applicable) within sixty (60) days following termination (or with respect to Section 9,
not later than seven (7) days before the Change in Control).

 

		11.	 RESTRICTIVE
COVENANTS.

 

(a)           CONFIDENTIALITY. During
the course of the Employee’s employment with the Company, the Employee will have access to Confidential Information. For
purposes of this Agreement, “Confidential Information” means all data, information, ideas, concepts, discoveries,
trade secrets, inventions (whether or not patentable or reduced to practice), innovations, improvements, know-how, developments,
techniques, methods, processes, treatments, drawings, sketches, specifications, designs, plans, patterns, models, plans and
strategies, and all other confidential or proprietary information or trade secrets in any form or medium (whether merely remembered
or embodied in a tangible or intangible form or medium) whether now or hereafter existing, relating to or arising from the past,
current or potential business, activities and/or operations of the Company or any of its affiliates, including, without limitation,
any such information relating to or concerning finances, sales, marketing, advertising, transition, promotions, pricing, personnel,
customers, suppliers, vendors, raw partners and/or competitors. The Employee agrees that the Employee shall not, directly or
indirectly, use, make available, sell, disclose or otherwise communicate to any person, other than in the course of the
Employee’s assigned duties and for the benefit of the Company, either during the period of the Employee’s employment or
at any time thereafter, any Confidential Information or other confidential or proprietary information received from third parties
subject to a duty on the Company’s and its affiliates’ part to maintain the confidentiality of such information, and to
use such information only for certain limited purposes, in each case, which shall have been obtained by the Employee during the
Employee’s employment by the Company (or any predecessor). The foregoing shall not apply to information that (i) was
known to the public prior to its disclosure to the Employee; (ii) becomes generally known to the public subsequent to
disclosure to the Employee through no wrongful act of the Employee or any representative of the Employee; or
(iii) the Employee is
required to disclose by applicable law, regulation or legal process (provided that the Employee provides the Company with prior
notice of the contemplated disclosure and cooperates with the Company at its expense in seeking a protective order or other
appropriate protection of such information).

 

    10

     

    

 

(b)           NONCOMPETITION. The
Employee acknowledges that (i) the Employee performs services of a unique nature for the Company that are irreplaceable, and
that the Employee’s performance of such services to a competing business will result in irreparable harm to the Company,
(ii) the Employee has had and will continue to have access to Confidential Information which, if disclosed, would unfairly and
inappropriately assist in competition against the Company or any of its affiliates, (iii) in the course of the Employee’s
employment by a competitor, the Employee would inevitably use or disclose such Confidential Information, (iv) the Company and
its affiliates have substantial relationships with their customers and the Employee has had and will continue to have access to
these customers, (v) the Employee has received and will receive specialized training from the Company and its affiliates, and
(vi) the Employee has generated and will continue to generate goodwill for the Company and its affiliates in the course of the
Employee’s employment. Accordingly, during the Employee’s employment and (A) if the Employee’s employment and
the Employment Term are terminated by the Company for Cause, by the Employee without Good Reason or as a result of the
Employee’s non-extension of the Employment Term as provided in Section 2 hereof, for a period of one (1) year
thereafter, or (B) if the Employee’s employment and the Employment Term are terminated by the Company other than for
Cause, by the Employee for Good Reason or as a result of the Company’s non-extension of the Employment Term as provided in Section 2
hereof and Employee was willing and able to remain employed, for a period of six (6) months thereafter, the Employee agrees
that the Employee will not, directly or indirectly, own, manage, operate, control, be employed by (whether as an employee,
consultant, independent contractor or otherwise, and whether or not for compensation) or render services to (i) any person,
firm, corporation or other entity, in whatever form, with a class of securities listed on a national securities exchange, engaged in
the business of owning and leasing agricultural real estate or in any other material business in which the Company or any of its
affiliates is engaged on the termination date or in which they have planned, on or prior to such date, to be engaged in on or after
such date, in any locale of any country in which the Company conducts business or (ii) any person, firm, corporation or other
entity, in whatever form, with assets under management or committed capital in excess of $100,000,000, engaged in the business of
owning and leasing agricultural real estate or in any other material business in which the Company or any of its affiliates is
engaged on the termination date or in which they have planned, on or prior to such date, to be engaged in on or after such date, in
any locale of any country in which the Company conducts business. Notwithstanding the foregoing, nothing herein shall prohibit the
Employee from (i) being a passive owner of not more than one percent (1%) of the equity securities of a publicly traded
corporation engaged in a business that is in competition with the Company or any of its affiliates, so long as the Employee has no
active participation in the business of such corporation or (ii) owning, managing, operating, controlling, or being employed by
any firm, corporation or other entity in the same capacity in which the Employee was engaged immediately prior to the Termination of
the Employee’s employment hereunder, as long as (a) the Board has been apprised of the identity of, and the
Employee’s role with, such firm, corporation or other entity and (b) the Board has previously approved the
Employee’s role with such firm, corporation or other entity, in the case of both (a) and (b), prior to the
Employee’s termination of employment. In addition, the provisions of this Section 11(b) shall not be violated
by the Employee commencing employment with a subsidiary, division or unit of any entity that engages in a business in competition
with the Company or any of its affiliates so long as the Employee and such subsidiary, division or unit does not engage in a
business in competition with the Company or any of its affiliates.

 

    11

     

    

 

(c)           NONSOLICITATION;
NONINTERFERENCE. (i) During the Employee’s employment with the Company and (A) if the Employee’s employment
and the Employment Term are terminated by the Company for Cause, by the Employee without Good Reason or as a result of the Employee’s
non-extension of the Employment Term as provided in Section 2 hereof, for a period of one (1) year thereafter, or (B) if
the Employee’s employment and the Employment Term are terminated by the Company other than for Cause, by the Employee for Good Reason
or as a result of the Company’s non-extension of the Employment Term as provided in Section 2 hereof and Employee was
willing and able to remain employed, for a period of six (6) months thereafter, the Employee agrees that the Employee shall not,
except in the furtherance of the Employee’s duties hereunder, directly or indirectly, individually or on behalf of any other person,
firm, corporation or other entity, solicit, aid or induce any customer of the Company or any of its affiliates to purchase goods or services
then sold by the Company or any of its affiliates from another person, firm, corporation or other entity or assist or aid any other persons
or entity in identifying or soliciting any such customer.

 

(ii)           During
the Employee’s employment with the Company and (A) if the Employee’s employment and the Employment Term are terminated
by the Company for Cause, by the Employee without Good Reason or as a result of the Employee’s non-extension of the Employment Term
as provided in Section 2 hereof, for a period of one (1) year thereafter, or (B) if the Employee’s employment
and the Employment Term are terminated by the Company other than for Cause, by the Employee for Good Reason or as a result of the Company’s
non-extension of the Employment Term as provided in Section 2 hereof and Employee was willing and able to remain employed,
for a period of six (6) months thereafter, the Employee agrees that the Employee shall not, except in the furtherance of the Employee’s
duties hereunder, directly or indirectly, individually or on behalf of any other person, firm, corporation or other entity, (A) solicit,
aid or induce any employee, representative or agent of the Company or any of its affiliates to leave such employment or retention or to
accept employment with or render services to or with any other person, firm, corporation or other entity unaffiliated with the Company
or hire or retain any such employee, representative or agent, or take any action to materially assist or aid any other person, firm, corporation
or other entity in identifying, hiring or soliciting any such employee, representative or agent, or (B) interfere, or aid or induce
any other person or entity in interfering, with the relationship between the Company or any of its affiliates and any of their respective
vendors, joint venturers, licensors or tenants. An employee, representative or agent shall be deemed covered by this Section 11(c)(ii) while
so employed or retained and for a period of six (6) months thereafter.

 

(iii)          Notwithstanding
the foregoing, the provisions of this Section 11(c) shall not be violated by (A) general advertising or solicitation
not specifically targeted at Company- related persons or entities, (B) the Employee serving as a reference, upon request, for any
employee of the Company or any of its affiliates so long as such reference is not for an entity that is employing or retaining the Employee,
or (C) actions taken by any person or entity with which the Employee is associated if the Employee is not personally involved in
any manner in the matter and has not identified such Company-related person or entity for soliciting or hiring.

 

    12

     

    

 

(d)           NONDISPARAGMENT.
The Employee agrees not to make negative comments or otherwise disparage the Company or its officers, directors, employees, shareholders,
agents or products other than in the good faith performance of the Employee’s duties to the Company while the Employee is employed
by the Company. The Company hereby covenants and agrees that it shall direct its directors and executive officers not to, directly or
indirectly, make or solicit or encourage others to make or solicit any negative comments or otherwise disparaging remarks concerning the
Employee. The foregoing shall not be violated by truthful statements in response to legal process, required governmental testimony or
filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings).

 

(e)           RETURN
OF COMPANY PROPERTY. On the date of the Employee’s termination of employment with the Company for any reason (or at any time
prior thereto at the Company’s request), the Employee shall return all property belonging to the Company or its affiliates (including,
but not limited to, any Company-provided laptops, computers, cell phones, wireless electronic mail devices or other equipment, or documents
and property belonging to the Company) after having the opportunity to delete any personal, non-business related information contained
on such property. The Employee may retain the Employee’s cell phone number as well as any rolodex and similar address books provided
that such items only include contact information.

 

(f)            REASONABLENESS
OF COVENANTS. In signing this Agreement, the Employee gives the Company assurance that the Employee has carefully read and considered
all of the terms and conditions of this Agreement, including the restraints imposed under this Section 11 hereof. The Employee
agrees that these restraints are necessary for the reasonable and proper protection of the Company and its affiliates and their Confidential
Information and that each and every one of the restraints is reasonable in respect to subject matter, length of time and geographic area,
and that these restraints, individually or in the aggregate, will not prevent the Employee from obtaining other suitable employment during
the period in which the Employee is bound by the restraints. The Employee acknowledges that each of these covenants has a unique, very
substantial and immeasurable value to the Company and its affiliates and that the Employee has sufficient assets and skills to provide
a livelihood while such covenants remain in force. The Employee further covenants that the Employee will not challenge the reasonableness
or enforceability of any of the covenants set forth in this Section 11. It is also agreed that each of the Company’s
affiliates will have the right to enforce all of the Employee’s obligations to that affiliate under this Agreement, including without
limitation pursuant to this Section 11.

 

(g)           REFORMATION.
If it is determined by a court of competent jurisdiction in any state that any restriction in this Section 11 is excessive
in duration or scope or is unreasonable or unenforceable under applicable law, it is the intention of the parties that such restriction
may be modified or amended by the court to render it enforceable to the maximum extent permitted by the laws of that state.

 

(h)           TOLLING. In
the event of any violation of the provisions of this Section 11, the Employee acknowledges and agrees that the
post-termination restrictions contained in this Section 11 shall be extended by a period of time equal to the period of
such violation, it being the intention of the parties hereto that the running of the applicable post-termination restriction
period shall be tolled during any period of such violation.

 

    13

     

    

 

 

(i)            SURVIVAL
OF PROVISIONS. The obligations contained in Section 11 hereof shall survive the termination or expiration of the Employment
Term and the Employee’s employment with the Company and shall be fully enforceable thereafter.

 

(j)            COOPERATION.
Upon the receipt of reasonable notice from the Company (including outside counsel), the Employee agrees that while employed by the
Company, the Employee will respond and provide information with regard to matters in which the Employee has knowledge as a result of the
Employee’s employment with the Company, and will provide reasonable assistance to the Company, its affiliates and their respective
representatives in defense of any claims that may be made against the Company or its affiliates, and will assist the Company and its affiliates
in the prosecution of any claims that may be made by the Company or its affiliates, to the extent that such claims may relate to the period
of the Employee’s employment with the Company.

 

12.          EQUITABLE
RELIEF AND OTHER REMEDIES. The Employee acknowledges and agrees that the Company’s remedies
at law for a breach or threatened breach of any of the provisions of Section 11 hereof would be inadequate and, in recognition
of this fact, the Employee agrees that, in the event of such a breach or threatened breach, in addition to any remedies at law, the Company,
without posting any bond or other security, shall be entitled to obtain equitable relief in the form of specific performance, a temporary
restraining order, a temporary or permanent injunction or any other equitable remedy which may then be available, without the necessity
of showing actual monetary damages. In the event of a violation by the Employee of Section 11 hereof, any severance being
paid to the Employee pursuant to this Agreement or otherwise shall immediately cease. If the Company adopts a “clawback” or
recoupment policy, payments under this Agreement will be subject to repayment to the Company to the extent so provided under the terms
of such policy.

 

13.          NO
ASSIGNMENTS. This Agreement is personal to each of the parties hereto. Except as provided in
this Section 13 hereof, no party may assign or delegate any rights or obligations hereunder without first obtaining the written
consent of the other party hereto. The Company may assign this Agreement to any successor to all or substantially all of the business
and/or assets of the Company, provided that the Company shall require such successor to expressly assume and agree to perform this
Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.
As used in this Agreement, “Company” shall mean the Company and any successor to its business and/or assets, which
assumes and agrees to perform the duties and obligations of the Company under this Agreement by operation of law or otherwise.

 

    14

     

    

 

14.          NOTICE.
For purposes of this Agreement, notices and all other communications provided for in this Agreement shall be in writing and shall be deemed
to have been duly given (a) on
the date of delivery, if delivered by hand, (b) on the date of transmission, if delivered by confirmed facsimile or electronic
mail, (c) on the first business day following the date of deposit, if delivered by guaranteed overnight delivery service, or
(d) on the fourth business day following the date delivered or mailed by United States registered or certified mail,
return receipt requested, postage prepaid, addressed as follows:

 

If to the Employee:

 

At the address (or to the facsimile number) shown in the
books and records of the Company.

 

If to the Company:

4600 S. Syracuse Street, Suite 1450

Denver, CO 80237

 

Attention: Chief Executive Officer

 

or to such other address as either party may have furnished to the
other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.

 

15.          SECTION HEADINGS;
INCONSISTENCY. The section headings used in this Agreement are included solely for convenience
and shall not affect, or be used in connection with, the interpretation of this Agreement. In the event of any inconsistency between the
terms of this Agreement and any form, award, plan or policy of the Company, the terms of this Agreement shall govern and control.

 

16.          SEVERABILITY.
The provisions of this Agreement shall be deemed severable. The invalidity or unenforceability
of any provision of this Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this
Agreement in such jurisdiction or the validity, legality or enforceability of any provision of this Agreement in any other jurisdiction,
it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by applicable
law.

 

17.          COUNTERPARTS.
This Agreement may be executed in several counterparts, each of which shall be deemed to be an
original but all of which together will constitute one and the same instrument.

 

18.          INDEMNIFICATION.
The Company hereby agrees to indemnify the Employee and hold the Employee harmless to the extent
provided under the By-Laws of the Company against and in respect of any and all actions, suits, proceedings, claims, demands, judgments,
costs, expenses (including reasonable attorney’s fees), losses, and damages resulting from the Employee’s good faith performance
of the Employee’s duties and obligations with the Company. This obligation shall survive the termination of the Employee’s
employment with the Company.

 

19.          LIABILITY
INSURANCE. The Company shall cover the Employee under directors’ and officers’ liability
insurance both during and, while potential liability exists, after the term of this Agreement in the same amount and to the same extent
as the Company covers its other officers and directors.

 

    15

     

    

 

20.          GOVERNING
LAW. This Agreement, the rights and obligations of the parties hereto, and any claims or disputes
relating thereto, shall be governed by and construed inaccordance with the laws of the State of Colorado
(without regard to its choice of law provisions). The parties acknowledge and agree that in connection with any dispute hereunder, Company
shall pay all costs and expenses, including, without limitation, its own and Employee’s legal fees and expenses. Notwithstanding
the above, if Company is the prevailing party in a dispute, it shall have the right to collect from Employee
reasonable costs and necessary disbursements and attorneys' fees incurred on behalf of Employee in the dispute.

 

21.          MISCELLANEOUS.
No provision of this Agreement may be modified, waived or discharged unless such waiver, modification
or discharge is agreed to in writing and signed by the Employee and such officer or director as may be designated by the Board. No waiver
by either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this
Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or
at any prior or subsequent time. Except with respect to any Equity Award Agreements, this Agreement together with all exhibits hereto
sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersedes any and all prior
agreements or understandings between the Employee and the Company with respect to the subject matter hereof. No agreements or representations,
oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not expressly
set forth in this Agreement. The payment or provision to the Employee by the Company of any remuneration, benefits or other financial
obligations pursuant to this Agreement and any indemnification obligations, shall be allocated between the Company and the Operating Partnership
by the Compensation Committee based on any reasonable method.

 

22.          REPRESENTATIONS. The
Employee represents and warrants to the Company that (a) the Employee has the legal right to enter into this Agreement and to
perform all of the obligations on the Employee’s part to be performed hereunder in accordance with its terms, and (b) the
Employee is not a party to any agreement or understanding, written or oral, and is not subject to any restriction, which, in either
case, could prevent the Employee from entering into this Agreement or performing all of the Employee’s duties and obligations
hereunder. In addition, the Employee acknowledges that the Employee is aware of Section 304 (Forfeiture of Certain Bonuses and
Profits) of the Sarbanes-Oxley Act of 2002 and the right of the Company to be reimbursed for certain payments to the Employee in
compliance therewith.

 

		23.	TAX MATTERS.

 

(a)           WITHHOLDING.
The Company may withhold from any and all amounts payable under this Agreement or otherwise such federal, state and local taxes as
may be required to be withheld pursuant to any applicable law or regulation.

 

		(b)	SECTION 409A COMPLIANCE.

 

(i)            The
intent of the parties is that payments and benefits under this Agreement comply with (or qualify for an exemption from) Internal
Revenue Code Section 409A and the regulations and guidance promulgated thereunder (collectively “Code
Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted accordingly. To
the extent that any provision hereof is modified in order to comply with Code Section 409A, such modification shall be
made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to the
Employee and the Company of the applicable provision without violating the provisions of Code Section 409A. In no event
whatsoever shall the Company (or its officers, directors, employees, agents, advisors or representatives) be liable for any
additional tax, interest or penalty that may be imposed on the Employee by Code Section 409A or damages for failing to comply
with Code Section 409A.

 

    16

     

    

 

(ii)            A
termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the
payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “separation
from service” within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement,
references to a “termination,” “termination of employment” or like terms shall mean “separation from
service.” Notwithstanding anything to the contrary in this Agreement, if the Employee is deemed on the termination date to be
a “specified employee” within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any
payment or the provision of any benefit that is considered deferred compensation under Code Section 409A payable on account of
a “separation from service,” such payment or benefit shall not be made or provided until the date which is the earlier
of (A) the expiration of the six (6)- month period measured from the date of such “separation from service” of the
Employee, and (B) the date of the Employee’s death, to the extent required under Code Section 409A. Upon the
expiration of the foregoing delay period, all payments and benefits delayed pursuant to this Section 23(b)(ii) (whether
they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed
to the Employee in a lump sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in
accordance with the normal payment dates specified for them herein.

 

(iii)           To
the extent that reimbursements or other in-kind benefits under this Agreement constitute “nonqualified deferred
compensation” for purposes of Code Section 409A, (A) all expenses or other reimbursements hereunder shall be
made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by the
Employee, (B) any right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another
benefit, and (C) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year
shall in any way affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year.

 

(iv)           For
purposes of Code Section 409A, the Employee’s right to receive any installment payments pursuant to this Agreement shall be
treated as a right to receive a series of separate and distinct payments. Whenever a payment under this Agreement specifies a payment
period with reference to a number of days, the actual date of payment within the specified period shall be within the sole discretion
of the Company.

 

(v)            Notwithstanding
any other provision of this Agreement to the contrary, in no event shall any payment under this Agreement that constitutes “nonqualified
deferred compensation” for purposes of Code Section 409A be subject to offset by any other amount unless otherwise permitted
by Code Section 409A.

 

    17

     

    

 

(vi)           To
the extent any compensation or benefit pursuant to Section 9 of this Agreement constitutes “nonqualified deferred compensation”
for purposes of Code Section 409A, if required to comply with Code Section 409A, a Change in Control shall not be deemed to
have occurred unless the transaction or event constituting the Change in Control also constitutes a “change in control event,”
as that term is used in Treas. Reg. Section 1.409A- 3(i)(5)(i).

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    18

     

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Agreement as of the date first written above.

 

		 	FARMLAND
                                            PARTNERS INC.

 

		 	By: 	/s/ Paul A. Pittman

 

		 	Name: Paul A. Pittman
	 	 	 
	 	 	Title: Chief Executive Officer
	 	 	 
	 	 	FARMLAND PARTNERS OPERATING PARTNERSHIP, LP

 

		 	By:	Farmland Partners OP GP, LLC, its general partner
	 	 	 	 

	 	 	By:	Farmland Partners Inc., its sole member
	 	 	 	 
	 	 	By:	/s/
Paul A. Pittman

 

		 	Name: Paul A. Pittman
	 	 	 
	 	 	Title: Chief Executive Officer

	 	 	 
	 	 	EMPLOYEE
	 	 	 
	 	 	/s/ James Gilligan
	 	 	 
	 	 	James Gilligan

 

    19

     

    

 

EXHIBIT A

 

GENERAL RELEASE

 

I,                        ,
in consideration of and subject to the performance by Farmland Partners Inc., a Maryland corporation (“Farmland”), and Farmland
Partners Operating Partnership, LP, a Delaware limited partnership (the “Operating Partnership” and, together with
the Farmland and its subsidiaries, the “Company”), of its obligations under the Employment Agreement dated as of [          ],
2021 (the “Agreement”), do hereby release and forever discharge as of the date hereof the Company and its respective
affiliates and all present, former and future managers, directors, officers, employees, attorneys, advisors, successors and assigns of
the Company and its affiliates and direct or indirect owners (collectively, the “Released Parties”) to the extent
provided below (this “General Release”). The Released Parties are intended to be third-party beneficiaries of this
General Release, and this General Release may be enforced by each of them in accordance with the terms hereof in respect of the rights
granted to such Released Parties hereunder. Terms used herein but not otherwise defined shall have the meanings given to them in the Agreement.

 

1.            I
understand that any payments or benefits paid or granted to me under Section 8 and Section 9 of the Agreement represent, in
part, consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand
and agree that I will not receive certain of the payments and benefits specified in Section 8 and Section 9 of the Agreement
unless I execute this General Release and do not revoke this General Release within the time period permitted hereafter. Such payments
and benefits will not be considered compensation for purposes of any employee benefit plan, program, policy or arrangement maintained
or hereafter established by the Company or its affiliates.

 

2.            Except
as provided in paragraphs 4 and 5 below and except for the provisions of the Agreement which expressly survive the termination of my employment
with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever discharge
the Company and the other Released Parties from any and all claims, suits, controversies, actions, causes of action, cross-claims, counter-claims,
demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys’
fees, or liabilities of any nature whatsoever in law and in equity, both past and present (through the date that this General Release
becomes effective and enforceable) and whether known or unknown, suspected, or claimed against the Company or any of the Released Parties
which I, my spouse, or any of my heirs, executors, administrators or assigns, may have, which arise out of or are connected with my employment
with, or my separation or termination from, the Company (including, but not limited to, any allegation, claim or violation, arising under:
Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967,
as amended (including the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the Americans with Disabilities
Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement
Income Security Act of 1974; any applicable Executive Order Programs; the Fair Labor Standards Act; or their state or local counterparts;
or under any other federal, state or local civil or human rights law, or under any other local, state, or federal law,
regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any policies, practices or
procedures of the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any
claim for costs, fees, or other expenses, including attorneys’ fees incurred in these matters) (all of the foregoing collectively
referred to herein as the “Claims”).

 

    A-1 

     

    

 

3.            I
represent that I have made no assignment or transfer of any right, claim, demand, cause of action or other matters covered by paragraph
2 above.

 

4.            I
agree that this General Release does not waive or release any rights or claims that I may have under the Age Discrimination in Employment
Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation from employment with
the Company in compliance with the terms of the Agreement shall not serve as the basis for any claim or action (including, without limitation,
any claim under the Age Discrimination in Employment Act of 1967).

 

5.            I
agree that I hereby waive all rights to sue or obtain equitable, remedial or punitive relief from any or all Released Parties of any kind
whatsoever in respect of any Claims, including, without limitation, reinstatement, back pay, front pay, and any form of injunctive relief.
Notwithstanding the above, I further acknowledge that I am not waiving and am not being required to waive any right that cannot be
waived under law, including the right to file an administrative charge or participate in an administrative investigation or proceeding;
provided, however, that I disclaim and waive any right to share or participate in any monetary award resulting from the
prosecution of such charge or investigation or proceeding. Additionally, I am not waiving (i) any right to the Accrued Benefits
or any severance benefits to which I am entitled under the Agreement, (ii) any claim relating to directors’ and officers’
liability insurance coverage or any right of indemnification under the Company’s organizational documents or otherwise, or (iii) my
rights as an equity or security holder in the Company or its affiliates.

 

6.            In
signing this General Release, I acknowledge and intend that it shall be effective as a bar to each and every one of the Claims hereinabove
mentioned or implied. I expressly consent that this General Release shall be given full force and effect according to each and all of
its express terms and provisions, including those relating to unknown and unsuspected Claims (notwithstanding any state or local statute
that expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those
relating to any other Claims hereinabove mentioned or implied. I acknowledge and agree that this waiver is an essential and material term
of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree
that in the event I should bring a Claim seeking damages against the Company, or in the event I should seek to recover against the Company
in any Claim brought by a governmental agency on my behalf, this General Release shall serve as a complete defense to such Claims to the
maximum extent permitted by law. I further agree that I am not aware of any pending claim of the type described in paragraph 2 above as
of the execution of this General Release.

 

7.            I
agree that neither this General Release, nor the furnishing of the consideration for this General Release, shall be deemed or construed
at any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct.

 

    A-2

     

    

 

8.            I
agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay all costs and expenses
of defending against the suit incurred by the Released Parties, including reasonable attorneys’ fees.

 

9.            I
agree that this General Release and the Agreement are confidential and agree not to disclose any information regarding the terms of this
General Release or the Agreement, except to my immediate family and any tax, legal or other counsel I have consulted regarding the meaning
or effect hereof or as required by law, and I will instruct each of the foregoing not to disclose the same to anyone.

 

10.            Any
non-disclosure provision in this General Release does not prohibit or restrict me (or my attorney) from responding to any inquiry about
this General Release or its underlying facts and circumstances by the Securities and Exchange Commission (SEC), the Financial Industry
Regulatory Authority (FINRA), any other self-regulatory organization or any governmental entity. Moreover,
notwithstanding any other provision of this Agreement: (A) I will not be held criminally or civilly liable under any federal or state
trade secret law for any disclosure of a trade secret that is made: (1) in confidence to a federal, state, or local government official,
either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law;
or (2) in a complaint or other document that is filed under seal in a lawsuit or other proceeding. (B) If I file a lawsuit for
retaliation by the Company for reporting a suspected violation of law, I may disclose the Company's trade secrets to the my attorney
and use the trade secret information in the court proceeding if: (1) I file any document containing the trade secret under seal;
and (2) I do not disclose the trade secret, except pursuant to court order.

 

11.            I
hereby acknowledge that Sections 8 through 14, 18 through 21 and 23 of the Agreement shall survive my execution of this General Release.

 

12.            I
represent that I am not aware of any claim by me other than the claims that are released by this General Release. I acknowledge that I
may hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the
subject matter of the release set forth in paragraph 2 above and which, if known or suspected at the time of entering into this General
Release, may have materially affected this General Release and my decision to enter into it.

 

13.            Notwithstanding
anything in this General Release to the contrary, this General Release shall not relinquish, diminish, or in any way affect any rights
or claims arising out of any breach by the Company or by any Released Party of the Agreement after the date hereof.

 

14.            Whenever
possible, each provision of this General Release shall be interpreted in, such manner as to be effective and valid under applicable law,
but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or
rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction,
but this General Release shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision
had never been contained herein.

 

    A-3

     

    

 

BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT:

 

		1.	I HAVE READ IT CAREFULLY;

 

		2.	I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO, RIGHTS UNDER THE AGE
DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963,
THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED;

 

		3.	I VOLUNTARILY CONSENT TO EVERYTHING IN IT;

 

		4.	I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL READING AND CONSIDERATION, I
HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION;

 

		5.	I HAVE HAD AT LEAST [21][45] DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT, AND THE CHANGES MADE SINCE MY
RECEIPT OF THIS RELEASE ARE NOT MATERIAL OR WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED [21][45]-DAY PERIOD;

 

		6.	I UNDERSTAND THAT I HAVE SEVEN (7) DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS RELEASE SHALL NOT BECOME
EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED;

 

		7.	I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY COUNSEL RETAINED TO ADVISE ME WITH RESPECT
TO IT; AND

 

		8.	I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY AN INSTRUMENT IN
WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME.

 

	SIGNED:	 	 	DATED:	 

 

    A-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]